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MEDICAL COLLEGE Alumni Bulletin 
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Beginning in 1824 with a faculty of five and 
two years later graduating its first class of 20 
new physicians, Jefferson now has a campus 
population of 2,400 undergraduate and 
graduate students in three colleges, 670 residents 
and fellows, and 3,200 full-time and part-time 
faculty. Tremendous benefits have accrued to 
society because of Jefferson people, both on campus 
and off campus. 
alumni and friends of Jefferson Medical 
College and Thomas Jefferson 
University in celebration of the 
175th anniversary of its founding. 
We honor our past, salute our 
present, and imagine our future. 
During this century and three-
quarters, Jefferson has grown from an 
aspiring newborn medical college to a 
strong university devoted to the health 
sciences. 
This year marks the 30th anniversary of the transfor-
mation into Thomas Jefferson University and the 
creation of the College of Health Professions (Allied 
Health Sciences). Moreover, it's the 50th year since the 
Board for Regulation of Graduate Studies was established 
(which in 1969 became the College of Graduate Studies). 
This special issue of the Alumni Bulletin is a gift to the 
o the alumni 
aila 
the leffesson COmmustity.. 
'This is ined- a special year fot the alumni of leffersonNiedical College , it 
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college has\ "The list 
of 
challenges, opportunities, and achievernents is extraor- 
dinary • 
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f stay in the acnte care hospial, the concept 
o
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Ameticans believe they sholda choose who should take case of them..Regrettably , 
aline-us environment has fostered expensive, defensive medicine. 
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creative 
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On the back cover: The certificate establishing the 
founding of Jefferson Medical College, signed on 
October 30, 1824. 
Jefferson has a proud record of educating excellent profes-
sionals, providing superior care to the sick and injured, and 
conducting basic, translational, and clinical research to 
increase mankind's knowledge. Emboldened by the fervor and 
dedication seen in the college's founder, Dr. George McClellan, 
we look forward, confident that the best is yet to come. 
On the cover: The doors of College Building, which 
opened in 1929 when Jefferson Medical College was 
just over a century old.  photo by Rick Echelmeyer 
anniversary 
e" 
_Itoemffear,s..Inefferson University 
*college of Graduate 
College _ 
 
College oef. 
rath'. Ruth:0
th 
Health Professions 
30th 
- 30th 
Editor 
Mary B. Monteith 
Associate Editor and Designer 
Malcolm Clendenin 
The quarterly magazine 
Published continuously since 1922 
Address correspondence to 
Attention: Alumni Bulletin 
Jefferson Medical College 
of Thomas Jefferson University 
1020 Locust Street, Suite M-41 
Philadelphia, PA 19107-6799 
Alumni Bulletin Office: 215 955 7920 
Fax: 215 923 9916 
Email: Malcolm.Clendenin@mail.tju.edu 
Website: http://jeffline.tju.edu/CWIS/ 
JMC/alumni/bulletin.html 
Additional copies of this issue, or of the 
Facts booklet, are available. The Jefferson 
community and supporters are welcome 
to receive the Bulletin on a regular basis. 
Please contact the address above. 
Postmaster: send address changes 
to the address above. Second class 
postage paid at Philadelphia, PA 
ISSN-0021-5821 
For information about giving to 
Jefferson, and alumni events: 
Phone: 215 955 7750 
Email: jmcalums@jeflin.tju.edu 
4 
5 
6 
8 
11 
12 
14 
17 
20 
22 
24 
26 
32 
40 
43 
43 
48 
50 
52 
53 
54 
55 
Jefferson Medical College Alumni Bulletin 
On-line at jeffline.tju.eduICIVISOMCIalumni/bulletin.html 
June 1999 
Volume XLVIII, Number 2 
Honor Our Past 
Meeting Challenges from the Start 
Developing the Curriculum 
Building a Campus 
Leaders in Their Fields: The 19th Century 
In the Nation's Service 
Keeping Pace for the 20th Century 
Salute Our Present 
A Comprehensive Medical School 
How Do We Monitor the Quality of the Education? 
The Jefferson Health System 
Education in the Health System 
Teaching under Managed Care 
A Student's Perspective 
JeffHOPE: Learning and Caring Go Hand in Hand 
Imagine Our Future 
Preparing Medical Students for the 21st Century 
Graduate and Continuing Education 
Basic Research 
Translational and Clinical Research 
Neurosurgery 
AIDS and Retroviruses 
Vaccines 
Connective Tissue 
The Future is Now 
Vital contributions to this issue were made by: 
John J. Gartland S'44, Chair, 
Publication Committee 
Renato L. Baserga, M.D. 
Paul C. Brucker, M.D. 
Robert L. Capizzi, M.D. 
E. J. Caterson '03 
Carlo M. Croce, M.D. 
Walter J. Curran Jr., M.D. 
Derek Davis 
Dolores A. Siegel DePersia '81 
James B. Erdmann, Ph.D. 
Lynn Gartland 
Joseph S. Gonnella, M.D. 
William V. Harrer '62 
Mohammadreza Hojat, Ph.D. 
Edward A. Jaeger OPH '64 
Gerald Litwack, Ph.D. 
Nicholas P. LoPresti '96 
Phillip J. Marone '57 
Bernard J. Miller '43 
Dorothy P. Mote 
Thomas J. Nasca '75 
David B. Nash, M.D., M.B.A. 
Roger J. Pomerantz, M.D. 
Susan L. Rattner, M.D. 
Joseph F. Rodgers '57 
Alfred C. Salvato 
J. Woodrow Savacool '38 
Stanton N. Smullens '61 
Jouni J. Uitto, M.D., Ph.D. 
J. Jon Veloski 
Frederick B. Wagner Jr. '41 
Dr. McClellan (an early daguerreotype 
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Honor Our Past 
Jefferson's heritage is the work of numerous individuals: faculty, 
staff, and alumni. The university's history has been illuminated by 
engaging teachers, thoughtful clinicians, and dedicated students, 
and by regional and national events shaped by the participation of 
Jeffersonians. 
Meeting Challenges 
from the Start 
It is easy to forget the early struggles of Jefferson Medical College 
before it matured into a stable and renowned medical center. It was 
one of the first institutions to pioneer clinical teaching for medical 
students—an enduring contribution to health care. 
The founder of Jefferson Medical College was George McClellan, 
M.D., who engaged in private practice of medicine and surgery near 
Sixth and Market Streets in Philadelphia, after graduating from the 
University of Pennsylvania School of Medicine in 1819. 
Like many prominent practitioners of the time, McClellan 
augmented his income by giving private lectures to medical students. 
He also allowed them to witness his operations and help care for 
patients. Involving students in care of the sick was a departure from 
the usual didactic, 
lecture hall teaching 
of the 1820s. This 
early clinical contact 
was the foundation 
on which Jefferson 
built its enviable 
reputation for 
producing doctors 
skilled in patient 
care. 
The increasing 
popularity of 
McClellan's lectures 
eventually persuaded 
him that there was 
need for a second 
medical school in 
Philadelphia. Turning this into a reality, however, proved difficult 
because of resistance from the entrenched medical community. But 
McClellan persisted, persuading the board of trustees of a small 
institution in Canonsburg, Pennsylvania—Jefferson College—to 
establish Jefferson Medical College, which could operate under the 
preexisting charter of Jefferson College. On April 7, 1826, the 
Pennsylvania legislature ratified this, which was necessary for the 
M.D. degree to be legal. 
The first students at Jefferson Medical College consisted of 109 
matriculants, of whom 20 graduated in the first class, in 1826. The 
formal curriculum consisted of four months of didactic lectures 
given during each of two successive years, augmented by bedside 
attendance. The combination of lectures and clinical demonstra-
tions, although initially derided by other medical schools, was 
unique and innovative. Eventually it became a model for all schools 
in the U.S. 
The original faculty of five, including McClellan, proved quite 
contentious for several reasons, among 
them jealousy over fees for the lectures. 
This dissension did not bode well for the 
quality of the education, and put the 
continued existence of the new school at 
peril. In June 1828 the trustees declared 
all the faculty chairs to be vacant and, in 
many instances, elected new professors 
to the vacated chairs. This did not stop 
the bickering. Tension escalated between 
McClellan and the trustees, resulting in 
McClellan's not being reelected to the 
Jefferson faculty in 1839. He left Jefferson and founded another 
medical school, which did not survive the Civil War. 
As more and more students enrolled at Jefferson, and the number of 
patients grew, the concomitant financial and legal demands were a 
strain on the tiny Jefferson College in western Pennsylvania. In 1838 
the state legislature approved the separation of the medical school 
from Jefferson College. Thus Jefferson Medical College became an 
independent, proprietary institution. Fifty-seven years later, in 
1895, Jefferson was to obtain yet a new charter, which would 
change its status from a proprietary to a nonprofit entity directed by 
a board of trustees. 
4 	 JEFFERSON Medical College Alumni Bulle n 	 June 1999 	 175th Year 
William Williams Keen Jr. '1862 teaching in the surgical amphitheater at Jefferson 
     
After 1841, when the board appointed a new faculty, came a long 
period of harmony and stability that saw many prestigious and 
productive individuals serve Jefferson as chairs. Robley Dunglison, 
M.D., who taught institutes of medicine and medical jurispru-
dence, had previously been on the faculty of the University of 
Virginia, where he had also served as physician to President 
Jefferson and President Madison. A prolific author, he became 
known as the father of American physiology. He served as dean 
from 1854 to 1868. By 1845 the student body had increased to 
469—the largest at any medical school in the United States. 
Developing the Curriculum 
The original course of study, consisting of didactic lectures and 
dissection and demonstrations of anatomy, lasted from November 
1 to March 1 for two years. In 1832 the college added a second 
term each year from April 1 to June 1 for more advanced students. 
By 1866, the curriculum for all matriculants lasted through 
October, occupying just about as much time as today. 
In addition to seeing patients in the private offices of faculty members, 
Jefferson students in the early years participated in the care of mostly 
indigent patients in a small dispensary and hospital, located in two 
commercial buildings that the faculty had purchased and converted. 
Also, Pennsylvania Hospital, located nearby at Eighth and Spruce 
Streets, permitted student access to patient care and teaching. Usually 
students accompanied staff members who served as their preceptors. 
Philadelphia General Hospital, known as the Almshouse or "Blockley," 
was another important site for clinical instruction. By the mid-19th 
century, Jefferson students were permitted access there through the 
efforts of Dr. Dunglison and Dr. Joseph Pancoast of the Jefferson 
faculty. Wills Eye Hospital, which opened in 1834, also began allowing 
Jefferson medical students to attend clinics. 
During the middle of the century, Jefferson Medical College required a 
written thesis from each candidate for the M.D. degree. This was 
abandoned in 1884 and replaced by written and oral examinations. 
Although the curriculum included observation of patients, actual 
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The 1877 Hospital 
physical examination and history taking were not 
yet a regular part of teaching. Stethoscopes, 
otoscopes, laryngoscopes, and ophthalmoscopes 
became available slowly during the second half of 
the 19th century, but student-patient contact was 
not close until its last decade. 
Similarly, research and investigative medicine 
were not extensive until the end of the 1800s. 
Prior to 1881, the only laboratory course taught 
was anatomy. But then the basic sciences quickly 
mushroomed, and rapid increases in knowledge 
obliged Jefferson Medical College to introduce 
laboratory courses in bacteriology, physiology, 
and pathology, for which a building was 
constructed at 10th and Sansom Streets. In 1906 
Jefferson had full-time teaching and research 
positions in anatomy, bacteriology, physiology, 
chemistry, and pathology. 
In 1891 Jefferson Medical College's curriculum 
had been extended to an obligatory three years 
and in 1895 to its present length of four years. In 
1916 the entrance requirement for admission to 
Jefferson was increased to two years of college 
preparatory work, including courses in 
physiology, chemistry, and biology. During the 
early twenties Jefferson began giving preference 
to college graduates. For the 1929-30 session, 
three years of college was a minimal prerequisite. 
Like many other medical schools, Jefferson did not require a four-
year college degree for admission until 1940. 
As the medical center grew, so did the need for allied health staff. 
The School of Nursing was established in 1891 (it became part of the 
College of Allied Health Sciences in the 1960s, now the College of 
Health Professions). Jefferson has awarded M.D. degrees every year 
since 1826, nursing certificates since 1893, and doctorates of 
philosophy, in fields of biomedical science, since 1949. The Board 
for the Regulation of Graduate Studies was established in 1949, 
becoming the College of Graduate Studies two decades later. 
Building a Campus 
The original Jefferson Medical College was confined to the rented 
Tivoli Theater building, located on today's Locust Walk; two 
commercial buildings converted to a dispensary and hospital; and 
the private offices of the faculty members. Soon more space was 
needed. 
Mainly through the efforts of the Reverend Ezra Stiles Ely, a trustee, 
the Ely Building, or Medical Hall, was built in 1829 on 10th Street 
between Sansom and Walnut. Jefferson's first surgical amphitheater, 
located on the second floor of the Ely Building, was the setting for 
The Gross Clinic, the 1875 painting by Thomas Eakins portraying 
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Samuel D. Gross '1828 teaching during an operation. (In 1878, this 
masterpiece was purchased for $200, and it still hangs at Jefferson 
today.) This amphitheater was also the place where, in 1846, 
Professor of Surgery Thomas D. Mutter, M.D. was the first in 
Philadelphia to demonstrate the use of ether for anesthesia—the 
dawn of a new epoch. 
In 1845, the Ely Building was enlarged: its front was extended 
forward, a Grecian facade with Corinthian columns was added, and 
another extension was built on the north side for lecture halls. The 
two commercial buildings were modified so their upper floors 
could connect with the Ely Building, and were enlarged to 
accommodate a total of 15 patients. 
This obviously could not remain adequate for long; the need for a 
separate hospital building became pressing. In 1872, a committee of 
the new Alumni Association of Jefferson Medical College was 
appointed to secure funds to purchase a site. During a time when a 
monetary panic was sweeping the country, this original fund-
raising effort totaled just over $350,000. In 1877, Jefferson's first 
definitive hospital was built on Sansom Street between 10th and 
11th: a five-story structure, modern in all respects, with full 
services and facilities, including a second surgical amphitheater. 
This was one of the first hospitals in America to be part of a medical 
college for teaching clinical skills to medical students at the 
bedside. 
In 1898, the Ely Building was demolished and superseded by a new 
academic building at 10th and Walnut Streets, to contain faculty 
offices, labs, and lecture halls. This in turn gave way to the present 
College Building erected in 1929. Adjoining the latter was the 
Curtis Clinic, originally used for outpatient care, which opened in 
1931. This structure was named for Cyrus H. K. Curtis of the 
Curtis Publishing Company, who donated a half million dollars for 
its construction. 
Daniel Baugh, a Philadelphia industrialist, served on Jefferson's 
board of trustees from 1896 until his death in 1921, upon which 
the board referred to him as "our greatest benefactor" in the 
school's 100-year history. His major interest as a trustee was to 
improve Jefferson's financial base. In 1910 he purchased a building 
at 11th and Clinton Streets, recently vacated by the Pennsylvania 
Dental College, and the adjoining edifice. He had them renovated, 
enlarged, and equipped for research and presented them to 
Jefferson's Daniel 
Baugh Institute 
of Anatomy 
(pastel drawing) 
Jefferson as quarters for the department of anatomy. The facility was 
named the Daniel Baugh Institute of Anatomy and served until 1968 
(following completion of Jefferson Alumni Hall, the department of 
anatomy relocated there from the Baugh building, which was sold 
and converted to condominiums). 
A new 300-bed hospital (still in use today and known as Old Main) 
was erected in 1907 at the corner of 10th and Sansom Streets, on the 
site of the Ely Building, Jefferson's first major structure. Patient care 
and bedside teaching were transferred to this new hospital. 
The lower floors of Thompson Annex, built in the college's 
centennial year adjacent to Main, held Jefferson's third and final 
amphitheater, which was used for surgical clinics from 1924 to 1966. 
The upper floors contained more patient rooms and surgical suites. 
Following completion of Thompson, campus expansion came to a 
standstill because no additional land was available. The turnaround 
occurred in the early 1950s, when the Philadelphia Redevelopment 
Authority allowed for the reconstruction of the Society Hill section 
of Philadelphia, just east of Jefferson. The reach of the 
Redevelopment Authority gave Jefferson the opportunity to buy 
property along Walnut, 10th, 11th, and Locust Streets. 
State-of-the-art was the term for the Foerderer Pavilion when it was 
built in 1954. Connecting on many floors to Thompson, it is still a 
major component of the clinical facilities. The Orlowitz Residence 
Hall went up in 1967. Next came Jefferson Alumni Hall, on the 
southern edge of the campus at Locust Street. It contains auditoria 
and commons facilities for students, with teaching laboratories and 
space for basic research on the upper floors. 
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The Scott Library and Administrative Building was added in 1970 
across from the present College Building. Jefferson's library was 
named after Samuel P. Scott, a lawyer from Hillsboro, Ohio, who, 
claiming to have been cured of a chronic respiratory ailment by an 
unnamed Jefferson professor, left a substantial endowment and his 
personal library of over 8,000 volumes to Jefferson on his death in 
1929. Behind the Scott Building were added benches, walkways, 
and fountains, as well as a historic statue of Samuel D. Gross '1828 
and an outdoor clock presented by the Class of '56. 
In 1972 Jefferson purchased the Edison Building at Ninth and 
Sansom Streets, and renovated it to house an innovative 
ambulatory care center and facilities for the College of Health 
Professions. 
The City of Philadelphia made additional land available to 
Jefferson in 1975. Part of this area was used for Barringer 
Residence Hall, named for Daniel M. Barringer and his son 
Brandon Barringer, both of whom had been dedicated members of 
Jefferson's board of trustees. 
A new Thomas Jefferson University Hospital was built in 1978, 
occupying an entire block between Sansom and Chestnut Streets. 
It was later named in honor of John H. Gibbon Jr. '27, developer of 
the first successful heart-lung machine. Innovations in design 
eased movement within the vast building. Four of the nine floors 
functioned as self-contained mini-hospitals, each with approxi-
mately 100 beds, focused on a particular medical problem. The 
preponderance of single patient rooms emphasized Jefferson's 
belief in the dignity of all patients regardless of ethnic origin, race, 
color, or economic status. The new facilities added 411 acute care 
beds; 110 new physician offices; diagnostic, therapeutic, and 
support services; and the Bodine Center for Cancer Treatment. 
Among the final pieces in the current campus were the Medical 
Office Building and Surgicenter built in 1986 at 11th and Walnut 
Streets, and the Bluemle Life Sciences Building erected at 10th and 
Locust in 1991. The latter represented a tremendous expansion of 
Jefferson's research space, for the departments of biochemistry and 
molecular pharmacology, dermatology and cutaneous biology, and 
microbiology and immunology, and basic research facilities of 
Jefferson's Kimmel Cancer Institute. 
Leaders in Their Fields: 
The 19th Century 
Jefferson's faculty and graduates have included remarkable figures in 
many fields of health care. Samuel D. Gross '1828 is writ large in any 
account of 19th-century American medicine. A lifelong student of 
surgery and pathology, Gross had published five textbooks by 1854, 
including works on the musculoskeletal system, pathologic anatomy, 
wounds of the intestines, urology, and foreign bodies in the air 
passages. In 1856, having established a national reputation at the 
University of Louisville, he joined Jefferson's faculty as the fourth 
chairman of surgery. Gross lost no time in exhibiting the knowledge 
and skill that earned him the sobriquet of father of American 
surgery. Students responded with profound respect to his lectures 
and clinics. 
Gross's System of Surgery, the most complete treatise of its kind in 
English, went through six editions and helped spread Jefferson's 
name throughout the world. In 1861, at the start of the Civil War, he 
wrote a manual of military surgery that was used by the Union 
military surgeons, pirated for use by the Confederacy, and later was 
translated into German and Japanese. Gross founded the 
Philadelphia Academy of Surgery, and was president of the American 
Medical Association, the American Surgical Association, and the 
World Medical Congress of 1876. He was the first president of 
Jefferson's Alumni Association, organized in 1870. 
J. Marion Sims, remembered as the father of American gynecology, 
graduated from Jefferson in 1835. He practiced in New York, where, 
in 1855, he founded the Woman's Hospital, the first of its kind in 
America. As a Southerner at the outbreak of the Civil War, he went 
to Europe and achieved considerable fame there before returning to 
New York. Although he never held an academic appointment, he is 
remembered for the Sims position in gynecologic surgery and for the 
Sims speculum. An expert on gynecologic cancer, he was involved in 
the founding of a hospital that evolved into Memorial Sloan-
Kettering Cancer Center. He served as president of the American 
Medical Association and of the American Gynecologic Society. 
Edward R. Squibb, a powerful advocate for pure food and drugs, 
graduated from Jefferson in 1845. His service in the Navy convinced 
him that many substances utilized in naval pharmacies were not only 
useless but downright harmful because of impurities. He became 
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The Gross Clinic 
particularly interested in sulfuric ether, which was used for 
anesthesia for the first time at Boston's Massachusetts General 
Hospital in 1846; Squibb noted the difficulty in regulating the level of 
the anesthesia. In 1852 he invented the process to purify sulfuric 
ether into pure ether, which led, in time, to the founding of E. R. 
Squibb and Sons for the manufacture of pure drugs. This enterprise 
survives today as part of the Bristol Myers Squibb pharmaceutical 
company. 
He was a tireless worker for national pure food and drug legislation 
but did not live to see his dreams come to pass. Squibb died in 1900, 
and in 1906 Congress passed the Pure Food and Drug Act, the 
beginning of a federal effort to control hazards related to food and the 
marketing of adulterated drugs and chemicals. 
S. Weir Mitchell, called the father of neurology, graduated from 
Jefferson in 1850. Although he never held an academic appointment, 
Mitchell, by virtue of his research activities in Philadelphia, became 
known as the greatest experimentalist of the 19th century; his contri-
butions bridged physiology and experimental medicine. His 1864 
publication Gunshot Wounds and Other Injuries of Nerves, based on his 
Civil War experiences and observations, laid the foundation for much 
of our modern understanding of neurologic symptoms and signs. 
Mitchell's reputation made Philadelphia a locus of his era's 
developing interest in experimental physiology. He made seminal 
contributions in neurology and psychiatry and was also highly 
regarded for his novels and poetry. He served as the first president of 
the Philadelphia Neurological Society in 1884 and as president of the 
American Neurological Association in 1909. 
William Smith Forbes '1852 joined the Jefferson faculty in 1879 as a 
demonstrator of anatomy and, in 1886, became the seventh chairman 
175 Years Celebrated in 
Special Exhibits 
Scott Library, Second Floor: 
175 Years of Medical Education, a detailed exhibit including 
historical materials from Jefferson, organized by Beth Bensman, 
University Archivist. 
In the Eakins Gallery: . Architecture at 
Jefferson Medical College: The First Century is a display of 
vintage photographs of college and hospital buildings designed 
for Jefferson by some of Philadelphia's leading architects of the 
19th and early 20th centuries, including Napoleon LeBrun, 
Frank Furness, James Windrim, and Horace Trumbauer. Some 
of these structures survive to the present (though slightly 
altered), for Jefferson has occupied the same area of Center 
City almost since its inception. The show was organized by 
Julie S. Berkowitz, University Art Historian. 
In Cyberspace: 
 Another exhibit is electronic: 
Jeff and its neighbor down Locust Street, the Historical Society 
of Pennsylvania, are both 175 years old this year, and in 
celebration, they have joined forces to create the Philadelphia 
Historical Digital Image Library (PHDIL). Anyone with Web 
access can visit it at http://jeffline.tju.edularchives/phdil/ 
PHDIL shows you images from the Thomas Jefferson 
University Archives and from the Historical Society. It 
documents health care, architecture, medical education, and 
life in Philadelphia during the 19th and early 20th centuries. 
Included are: 
• Pre-1945 portraits of JMC alumni, faculty, and trustees 
• Photographs of military hospitals 
• Medical society and class portraits 
• Views of anatomy labs, operating rooms, and clinics 
• Images of Philadelphia hospitals 
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Jefferson's board of trustees from 1951 to 
attempt to specialize 
caused much derision 
among his colleagues. 
His portrait hangs 
outside the Solis-
Cohen Auditorium in 
Jefferson Alumni Hall, 
along with those of his 
brother Solomon 
(Class of 1883) and his 
nephew D. Hays Solis-
Cohen, a member of 
1970. 
of anatomy. In this period, cadavers were not readily available for 
student dissection, though considered essential. The only cadavers 
available to medical schools were unclaimed bodies or those that had 
undergone capital punishment. With student enrollments increasing, 
there developed a concomitant illicit trade, in which grave robbers 
sold bodies to medical schools. Thanks mostly to the efforts of 
Forbes, the Pennsylvania legislature passed the Anatomy Act of 1867 
(amended in 1883), which provided for the legal procurement and 
equitable distribution of cadavers for teaching and scientific investi-
gation at the various institutions in the commonwealth. This act 
served as a model for other states and put an end to the practice of 
body snatching and grave robbing. 
Dr. DaCosta 
Dr. Finlay 
Dr. Jackson 
Jacob Mendez DaCosta '1852, the seventh chairman of medicine 
(1872-91), was the author of an 1864 treatise, Medical Diagnosis, 
which went through nine editions and was translated into several 
foreign languages. His classic description of "irritable heart" in 1871 
marked him as a pioneer in cardiology. Much of his clinical work 
was conducted in Jefferson's first true hospital, built in 1877. He 
received honorary LL.D. degrees from Jefferson, the University of 
Pennsylvania, and Harvard. 
Carlos Juan Finlay, forever linked 
with the conquest of yellow fever, 
graduated from Jefferson in 1855 with 
an open, questioning mind and an 
interest in the use of the microscope. 
He returned to his native Cuba and 
began a general practice, where he 
identified the mosquito Aedes aegypti 
as the agent responsible for 
transmitting yellow fever to humans. 
Subsequent experiments carried out by the U.S. Army proved Finlay 
correct. Finlay's work resulted in the eradication of yellow fever as 
one of the world's great plagues. He was widely praised, and 
Jefferson awarded him an honorary doctor of science degree in 1902. 
Jacob da Silva Solis-Cohen, M.D. joined the Jefferson faculty in 1867 
and became the most distinguished laryngologist of the 19th century. 
He was the first to perform a laryngotomy and a total laryngectomy 
in America, he wrote the first textbook on diseases of the throat and 
nasal passages, and in 1878 he founded the American Laryngological 
Association. He was unusual in confining his clinical interest to 
diseases of the larynx. This was the era of the generalist, and his 
After graduating from Jefferson in 1862, William Williams Keen Jr. 
was appointed acting assistant surgeon in the army, where he quickly 
brought order to Union medical units that had been chaotic. He later 
served with S. Weir Mitchell '1850, whom he assisted in studying 
nerve injuries; thus began Keen's lifelong interest in neurological 
surgery. By 1889 he had progressed to the chair of surgery at 
Jefferson. His operative skills, teaching ability, and writing made him 
a peer of William Halsted and Harvey Cushing at Johns Hopkins, a 
worthy successor of Samuel D. Gross and a giant in American 
surgery. He was the first to successfully remove an intracranial tumor 
and among the first to adopt the Listerian principles of antisepsis. He 
was considered the father of brain surgery in this country. His System 
of Surgery was the preeminent text in the United States in the first 
decade of the 20th century. 
Chevalier Jackson '1886, second 
chairman of laryngology (1916-24) 
and first chairman of bronchoe-
sophagology (1924-30), had been 
encouraged in his interest in 
laryngology by Professor Solis-Cohen. 
Of a mechanical bent, Jackson invented 
and improved instruments for the 
removal of foreign bodies from the food 
and air passages. He became noted 
worldwide for his innovations in bronchoscopy and laryngeal 
surgery. His book, Bronchoscopy and Esophagoscopy: A Manual of 
Peroral Endoscopy and Laryngeal Surgery, became a bible in its field. 
In addition to his clinical work, he launched constant campaigns to 
prevent children from inhaling or swallowing foreign objects. One of 
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Dr. Letterman 
Jackson's greatest public contributions was to inspire the passage of 
a federal caustic poison law in 1927. 
The founding of the Association of American Medical Colleges 
occurred at Jefferson in 1876, and Jefferson's dean, John B. Biddle, 
M.D., was elected the organization's first president. He served until 
1879 when he was succeeded by Samuel D. Gross '1828. The tradition 
of service to the AAMC, which helps maintain academic standards for 
medical education nationwide, continued to Jefferson's current dean, 
Joseph S. Gonnella, M.D., who was awarded the AAMC's prestigious 
Flexner Award for extraordinary contributions to medical education 
in October 1998. 
In the Nation's Service 
Jefferson Medical College was affected greatly by the Civil War, and 
contributed knowledge and care, as it has to every major succeeding 
conflict. The college had attracted a large number of students from the 
South, many of whom felt the call of duty to the Confederate cause. 
In December 1859, when hostilities between the North and the South 
seemed imminent, approximately 200 Southern students left Jefferson 
to transfer to Southern medical schools or to serve their states' cause. 
General George Brinton McClellan, son of Jefferson's founder, 
commanded the Army of the Potomac and eventually became general 
in charge of the Union forces. His relative John Hill Brinton '1852, 
later the cochairman of surgery (1882-1906), entered the Union Army 
as a brigade surgeon of volunteers. Appalled by the army's medical 
standards, which were both deficient and in disarray, he founded an 
army medical and surgical society that brought together surgeons 
from Illinois, Iowa, Michigan, and Missouri to share their knowledge. 
In 1862 the U.S. Surgeon General requested Brinton to write the 
Surgical History of the Rebellion, intended to improve the treatment of 
the sick and wounded. Later Brinton was assigned to collect and 
arrange all specimens of morbid anatomy that had accumulated in the 
various military hospitals during the conflict. This work, which was 
vital to medical study because it organized a vast amount of clinical 
data, laid the foundation for the United States Army Medical Museum. 
Jonathan Letterman '1849 made perhaps the greatest contribution of 
Jeffersonians to the care of sick and wounded personnel. During the 
Civil War he established methods for the rapid evacuation of the 
injured, designing vehicles that were 
dedicated solely to clearing the 
wounded from the battlefield. Thanks 
to Letterman, military ambulances, 
medical airplanes, and medical 
helicopters remain under the direction 
of the Army Medical Department to this 
day. The Letterman Army Medical 
Center in San Francisco was named in 
his honor. 
Ninian Pinckney '1833 enlisted in the Union naval forces and 
eventually became medical director with the rank of commodore. He 
was known for an innovation that helped both the Army and the 
Navy: he outfitted a captured Confederate side-wheeler, the Red 
Rover, equipped it with elevators, window screens, and operating 
rooms, and used it as a hospital ship. Catholic nuns volunteered as 
nurses. This is believed to be the first navy hospital ship that carried 
female nurses to care for the wounded. 
Shortly after the United States entered World War I, the government 
realized that the armed forces medical corps would need help coping 
with the anticipated large numbers of injured. The Red Cross 
organized 50 hospitals across the country in support of the American 
expeditionary force that headed for France in early 1918. These base 
hospitals were to be transferred to the jurisdiction of the U.S. Army 
Medical Department after mobilization. The idea was to assemble a 
group whose members were accustomed to working with each other 
so the unit could function quickly at an efficient level. 
Jefferson professionals staffed Base Hospital 38, with 50 medical 
officers and 100 enlisted personnel. William M. L. Coplin '1886, 
chairman of pathology, was named commanding officer. Base 
Hospital 38 established itself in Nantes, France, where approximately 
9,000 war casualties were treated before November 1918. 
In 1940 when involvement of the United States in World War II 
seemed probable, the Surgeon General of the Army, James C. Magee 
'05, asked Dean William H. Perkins, M.D. to reorganize Base 
Hospital 38. Baldwin Keyes '17 was named commanding officer, and 
Edna Scott director of nurses. By the time of the Japanese attack on 
Pearl Harbor, Base Hospital 38 was ready for active duty. Assigned to 
Cairo, Egypt to support the North African campaign, it was 
eventually cited for outstanding service by Commanding General 
Giles of the African Middle East Theater in 1945. 
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An effect of World War II was the creation of the Student Army 
Training Corps for those enrolled in the nation's medical schools 
between 1942 and 1945. Because it was feared that the United States 
faced a long and difficult fight, requiring an ample supply of 
physicians, the government took over all U.S. medical colleges. Every 
able-bodied student had to choose the army or the navy for service 
following graduation. In return the government paid the students' 
tuition. 
The Classes of '44 and '45 were the classes most affected by the 
accelerated curriculum, with each graduating nine months early 
(becoming the Classes of J'44 and S'44). Every new doctor in the 
army program had an internship of nine months, with a commission 
as first lieutenant in the army medical corps and orders to active 
duty. In all, 2,122 Jefferson graduates, almost one-third of living 
alumni at the time, served in World War II. 
Keeping Pace for the 
20th Century 
In 1904 the American Medical Association had identified education 
as an area of health care gravely in need of reform. Schools were 
flooding the country with poorly educated physicians, more than 
half of whom took no internship prior to going into practice. The 
upshot was the appointment of Abraham Flexner in 1909 to survey 
medical education in the United States and Canada, on behalf of the 
Carnegie Foundation for the Advancement of Teaching. The Flexner 
Report was issued the next year. 
Flexner visited 155 medical schools, including seven in Canada. The 
evaluation included the entrance requirements, enrollment, teaching 
staff, sources of funding, laboratory facilities, and clinical facilities. 
The AMA and the AAMC vowed to carry out Flexner's recommenda-
tions. The result was that 76 medical schools went out of business 
between 1906 and 1920, either by ceasing to function or by merging 
with stronger institutions. 
Flexner gave Jefferson a favorable rating. His report states, "Of all 
independent schools outside of New York State, this institution 
comes nearest to obtaining its published entrance requirements." He 
commended the library, museum, laboratories, and other teaching 
facilities. He also complimented Jefferson on its long tradition of 
clinical teaching and noted that students were freely admitted to the 
hospital wards and clinical laboratory. Jefferson was one of a few 
independent medical schools to survive Flexner's conclusion that 
affiliation with a university was essential for any medical school. 
Because university ownership was one of the goals sought by the 
Flexner Report and because Jefferson remained independent, it was 
not until October 1914 that the AAMC granted Jefferson full accred-
itation. At that time, it placed Jefferson in the A-plus category of 
American medical colleges. 
Jefferson produced 
doctors worthy of such 
a rating. John H. 
Gibbon Jr. '27, the 
Samuel D. Gross 
Professor of Surgery, 
will be remembered 
forever as the 
developer of the heart-
lung machine that 
made open heart 
surgery possible. The 
device was used in 
open cardiotomy for 
the maintenance of 
cardiorespiratory 
functions during the 
repair of congenital intracardiac defects. Bernard J. Miller '43 
became Gibbon's research associate in 1950 and developed essential 
details of the heart-lung apparatus. A mechanical ventilator, well 
known as the Jefferson ventilator, was developed by George J. 
Haupt '48. 
On May 6, 1953, Gibbon successfully repaired a large interatrial 
septal defect in a young female patient during total cardiac bypass 
using his new heart-lung machine. The surgical team included Dr. 
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Frank Allbritten Jr. and John J. McKeown Jr. '47. Dr. Miller operated 
the heart-lung machine during the procedure. The surgery was 
successful, and the patient has enjoyed a long, healthy life. This 
epoch-making event ushered in the era of high-technology surgery. 
The Cardeza Foundation for the Study of Diseases of the Blood was a 
primary source of research pride at Jefferson. It was established at 
Jefferson in 1941 through the generosity of the Cardeza family, and 
its director held the Cardeza Professorship. Allan J. Erslev, M.D., 
who held this post from 1963 to 1985, achieved international fame 
for the discovery of erythropoietin, a renal hormone that controls the 
rate of red blood cell production, and plays a major role in recovery 
from blood loss, and in adaptation to high altitudes. Erythropoietin 
has become a valuable agent for treating certain anemias, particularly 
those related to renal dialysis. 
A tradition of 137 years at Jefferson was broken in September 1961 
with the matriculation of female medical students, making Jefferson 
the last all-male medical school to become coeducational. At 
graduation in 1965, seven women were granted diplomas. In 1989 a 
member of that class, Nancy S. Czarnecki, M.D., was elected the first 
female Alumni President. 
The advisability of Jefferson gaining university status, either on its 
own or by affiliating with an existing university, had been discussed 
on campus intermittently since the Flexner Report. Peter A. Herbut, 
M.D. actively pursued university status for Jefferson after his 
appointment as President in 1966 (his prior service had been as 
Chairman of Pathology). A charter granting university status was 
issued by the Commonwealth of Pennsylvania three years later, and 
Thomas Jefferson University was established on July 1, 1969 as a 
health-related, medically oriented university with four divisions: 
Jefferson Medical College, the College of Graduate Studies, the 
College of Allied Health Sciences, and Thomas Jefferson University 
Hospital. 
Lewis W. Bluemle Jr., M.D. served a 
widely lauded term as the university's 
second President, from 1977 until 
1990, and was followed by Paul C. 
Brucker, M.D., previously Chairman of 
Family Medicine. These decades have 
been strong ones, marked by new 
initiatives and prudent responses to 
nationwide changes in health care. 
Since its founding in 1824, Jefferson 
Medical College had earned an enviable reputation for clinical 
excellence and for producing good doctors. But until 1980, except 
for a few bright spots like the Cardeza Foundation, sponsored 
research was not fostered. During the 1980s, Dean Gonnella foresaw 
that, to survive in an increasingly competitive health care and 
academic environment, Jefferson had to add a significant component 
of laboratory investigation. The board of trustees agreed that the 
research faculty and facilities should be broadened, for the vitality of 
a university depends on nurturing the discovery of new information 
and the testing of new theories. Now, well equipped laboratories, a 
superb medical library, and exceptional faculty cultivate ideas, 
keeping Jefferson in its proper place in the forefront of medicine.4 
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Salute Our Present 
We are now in an era that is particularly challenging for 
medicine. The fizzling of health care reform in 1994 was 
followed by the ascendancy of managed care. This has caused 
profound changes not only in how medicine is practiced, but 
also in how it is taught. A major step taken by Jefferson was 
the formation of the Jefferson Health System, a partnership 
of Thomas Jefferson University Hospital with multiple other 
institutions in the Philadelphia region, over 600 primary 
care physicians, and a large number of medical and surgical 
specialists. Jefferson operates in a very competitive and 
volatile health care market which tests the best in those 
administering the university and the health system. 
Managed care has transformed the way students learn 
clinical skills. No longer are large numbers of inpatients 
available for teaching, because the focus of care has shifted 
to the outpatient arena. Therefore ambulatory clinic experi-
ences have become a focus of instruction. So has the 
knowledge of health economics that students will need to 
practice cost-effectively and to interact with insurance 
providers. 
In spite of the challenges posed by the local and national 
environment, Jefferson has strengthened its educational, 
clinical, and research components, and has gained 
recognition as one of the best-balanced medical schools in 
the country. 
Clinical Assistant Professor 
Gary Emmett '76 with a 
pediatric patient 
A Comprehensive 
Medical School 
I,  r -the core mission of a medical college is undergraduate medical 
_ education to prepare the next generation of physicians. 
Inextricably linked to this are the other two legs of "the academic 
stool," patient care and research. The balance struck among these 
three determines the spirit and the resource allocation of a 
particular institution. At some schools, research is the primary 
emphasis. At others, teaching is the principal focus, with patient 
care utilized for the clinical phase of education, but with limited 
emphasis on research. 
Jefferson is among a small number of medical schools that have 
intentionally developed programs of depth in all three dimensions: 
education, patient care, and research. We believe this balanced 
approach is essential to the development of medical students, 
graduate students, residents, and faculty. 
The 11th oldest medical school in the United States, Jefferson 
Medical College remains one of the largest, with 223 entering 
medical students per year. Selected from an applicant pool of 9,000 
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performance and satisfaction remain similar at each of our affiliated 
teaching hospitals in all courses across many years, demonstrating 
the faculty's consistent commitment to excellence. 
to 11,000 per year, each class presents outstanding academic 
credentials and a diversity of backgrounds and interests. 
Graduating seniors over the past seven years have rated the 
quality of the Jefferson education very highly, at an average of 
eight on a scale of one to 10. They rate it even higher when asked 
some years following graduation, after they have had a chance to 
compare their preparation with that of peers from other 
institutions. 
More than two-thirds of graduating seniors receive one of their 
first three choices in the National Residency Matching Program. 
Jefferson's alumni perform at a high level, as judged by their 
residency program directors during their first year of postgraduate 
training. Over 85 percent of Jefferson's alumni are ranked in the 
top half of their internship class. This level of excellence has been 
measured and sustained for over 25 years. 
Jefferson remains committed to a comprehensive curriculum that 
provides the student with experiences across the full range of 
medical, surgical, and support disciplines, across age ranges of 
neonates to geriatrics. While this approach is somewhat 
constraining on the flexibility of fourth year students' elective 
opportunities (they are limited to three electives), it means that 
we graduate young physicians with great breadth of knowledge 
and skills, including behavioral skills. The faculty and adminis-
tration remain convinced that broad preparation in medical 
school followed by specialization in graduate medical education 
produces the strongest clinicians and researchers. 
Jefferson is maintaining excellence in the clinical phase of 
instruction even as the nation's health care delivery system 
undergoes dramatic change. The college has joined with its 
partners in the Jefferson Health System, as well as its other loyal 
affiliated teaching hospitals, to ensure the quality of 
undergraduate and graduate medical education. Excellence in the 
performance of our alumni is a direct result of the teaching of our 
faculty at each of our affiliated institutions and office practices, 
working in concert with the faculty on the main campus. Student 
esearch at Jefferson has reached significant levels. Investment 
n infrastructure and faculty has yielded dramatic growth in 
basic science investigation. Jefferson achieved the second highest 
institutional rate of growth in National Institutes of Health funding 
over a recent 10 year period. 
The basic, translational, and clinical research programs of Jefferson 
now rank in the upper third of all medical schools in the U.S. as 
judged by NIH direct monetary awards. If we keep to our goal of 
achieving a position in the top 25 percent, our balance among 
education, patient care, and research can be sustained. 
The challenge of maintaining excellence as a comprehensive school 
will escalate as we enter the millennium. NIH research funding may 
increase in total dollars, but will likely be concentrated in a smaller 
number of institutions. Maintenance of a position in the top 25 
percent of all institutions will require continued significant 
investment in facilities and faculty. The administration has 
embarked upon a program to expand our laboratory space by 25 
percent. 
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First down in the snow: Jeff students are game for a December study break. 
The college remains committed also to leadership in research on 
medical education and health services. Our Center for Research in 
Medical Education and Health Care has achieved international 
recognition for its pioneering work in establishing the Longitudinal 
Study of graduates of Jefferson Medical College, and the study of 
the processes and outcomes of medical education at Jefferson. With 
over 75 peer review publications documenting predictors of perfor-
mance, outcomes of educational interventions, and longitudinal 
performance of our graduates, the college has contributed greatly to 
the national understanding of the process of medical education, 
and framed the current national discussion of the outcomes of 
medical education. 
Jefferson's superb reputation for patient care is sustained by the full 
time and volunteer faculty. The stresses on the health care system 
have had a major impact on the way care is delivered by our 
faculty. Despite the pressures, Thomas Jefferson University Hospital 
continues to expand, offering innovative services to its patients, 
and meeting the needs of our doorstep community and the broader 
region. A manifestation of success is the hospital's recent inclusion 
as one of HCIA-Mercer's "100 Top Hospitals" in the United States. 
The leaders of the hospital and the university, along with our 
partners in the Jefferson Health System, are developing effective 
approaches to delivering care across the tri-state area. Now the 
largest health system in southeastern Pennsylvania, JHS improves 
the health status of more than 1.25 million citizens. Through the 
university hospital and the system, we seek to provide leadership in 
methods of delivering care, as well as to enhance these important 
sites for education and for clinical research. 
Competition in the tri-state region will heighten over the next 
decade, as we feel the impact of excess hospital and physician 
capacity, and the entry of for-profit institutional providers into the 
Philadelphia market. The costs of technology in patient care will 
continue to escalate. Continuing the tradition of excellence will 
require judicious planning, and the full integration of the university 
with the providers of patient services. 
Jefferson must continue to enhance its prominence through 
continued innovation in 
• how we evaluate programs and trainees, 
• how we measure outcomes, and 
• our methods of instruction. 
New, more effective models of continuing medical education must 
be developed which assist the practicing physician to acquire not 
only medical knowledge, but also the skills and behaviors to 
provide cost effective care in our changing health care climate.( 
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How Do We Monitor the Quality of Student Education 
in the Changing Clinical Arena? 
until the latter part of the 20th century the hospital was the nucleus of health care delivery and the preferred location for 
clinical education. In the teaching hospital medical students were 
able to learn comprehensive diagnosis and disease management as 
they cared for a wide array of patients with a broad spectrum of 
problems. However, economic forces coupled with technological 
breakthroughs in the past few decades have cut the time that 
patients spend in hospitals. Now many diagnostic studies, 
surgical procedures, and other services once provided only in 
inpatient settings are available in ambulatory surgical centers, 
walk-in clinics, short or long term nursing facilities, doctors' 
offices, and even patients' homes. Fewer and fewer patients are 
being admitted to the hospital for ever shorter lengths of stay. 
In anticipation of these trends, Jefferson in 1974 made what was 
then a bold move to become the first medical school to require a 
core, ambulatory clinical rotation in family medicine. Although 
inpatient settings are still needed for comprehensive clinical 
education, opportunities abound in other sites of care. Through 
the 1990s faculty members in nearly every discipline have been 
reassessing student programs and clinical experiences, and 
increasing instruction in ambulatory sites. 
These trends have underscored the need to track the quality of 
clinical education, using objective indicators to guide interven-
tions and to assist the faculty in evaluating the impact of changes 
they may make, across diverse clinical settings. 
Early in the 1980s, Associate Dean Joseph F. Rodgers '57 began 
working with the clinical departments to gather systematic data 
about the quality of core clerkships throughout Jefferson's 
farflung affiliates (student education involves multiple institu-
tions, some within and some outside the Jefferson Health 
System). 
Working with researchers in Jefferson's Center for Research in 
Medical Education and Health Care, Dr. Rodgers defined three 
sets of quality indicators that are still being used to monitor 
education in the clerkships. 
The first and most important indicator is learning as measured by 
written faculty evaluations of each student's clinical performance, 
and by a uniform, objective written examination administered at 
the end of every block. Learning is also assessed over the long 
term by tracking students' performance after graduation in their 
residencies and subsequent practices. 
The second set of quality indicators involves students' self-reports 
of their educational experiences during each clerkship and their 
personal evaluations of the program, attending physicians, and 
residents. At the end of each core clerkship, medical students 
complete a brief questionnaire on many facets of the clerkship 
such as 
• the clarity of goals and their achievement, 
• the relative role of attendings and residents in the educational 
program, and 
• the conduct of formal conferences and teaching rounds. Over 90 
percent of students respond to this confidential survey which is 
standardized across all clerkships and clinical sites. This standard-
ization allows departments and individual sites to compare 
themselves to one another, and also to monitor their own perfor-
mance across time. 
The third set of quality indicators reflects the intensity of students' 
clinical experiences and quantity of their patient encounters. For 
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many years this has included students' retrospective self-reports of 
the average number of hours spent on duty and on call, and the 
average number of new patients per week. In addition, the 
Departments of Family Medicine, Internal Medicine, and 
Pediatrics now require every student to complete a detailed 
encounter form for all significant patient interactions. This 
provides extensive data which the faculty can use to assess differ-
ences in case mix, across settings or over time. 
For each core clerkship, we also track the percentage of students 
who eventually enter that particular specialty after graduation. 
Although this is not viewed as an indicator of quality, many 
professors want to be aware whether trainees develop an interest 
in their specialty. 
Periodically, the teaching coordinators, key faculty, and adminis-
trators from the affiliated teaching sites meet to review the trends 
in data on their clerkships. Using an interactive computer system 
devised at Jefferson they can query the database and see how they 
compare to other hospitals and other clerkships. With graphic 
displays as well as traditional statistical indices, they can see 
trends for their clerkships over time. Graphs and tables are shared 
with other key faculty at their hospital. 
For example, during the past decade there have been calls to 
assure that students receive adequate ambulatory clinical experi-
ences. Students' reports show that on average they see at least 20 
new patients per week in their family medicine and pediatric 
clerkships. Furthermore, the data indicate that this number has 
been increasing over the decade. Comparisons are made across 
institutions and across departments and action is taken where 
needed. 
As it expands clerkship opportunities in a changing environment, 
Jefferson is absolutely committed to assuring the quality of 
students' clinical training.( 
There have been profound changes at Jefferson Medical College 
over the past 175 years: curricula; equipment and facilities; 
the physician's altered role in health care; computers and the 
Internet; and in 1961, the admission of women. At Jefferson 
and nationwide, the public's perception of doctors has been 
forever transformed by the presence of women in medical 
school. The class of 2002 entered Jefferson Medical College 
with 50 percent women and the medical school faculty is now 
25 percent female. These statistics are a stark contrast to the 
environment which earlier alumni experienced during their 
days at the Jefferson campus. The evolution of the 
demographics has been slow but steady. The proportion of 
women matriculating at the medical college was less than seven 
percent in 1964. Since that time, our female graduates have 
made crucial contributions to Jefferson Medical College, our 
community, and the medical profession nationally. 
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Jerson 
Health System 
uring the 1990s the health care environment in the 
Philadelphia metropolitan area has been volatile and 
uncertain, replete with hospital mergers and acquisitions. To 
serve the needs of its community and to work effectively under 
managed care, Jefferson explored alliances and partnerships. 
In August 1995 Thomas Jefferson University and the Main Line 
Health System signed an agreement establishing a new, 
nonprofit, corporate entity known as the Jefferson Health 
System, an integrated health care delivery system, including 
Thomas Jefferson University Hospital, Methodist Hospital, Bryn 
Mawr Hospital, Bryn Mawr Rehab, Lankenau Hospital, and 
Paoli Memorial Hospital. Since then, other established institu-
tions have joined JHS, including the Albert Einstein Healthcare 
Network, Frankford Health Care System, and Magee 
Rehabilitation Hospital. 
Albert Einstein Healthcare Network comprises Albert Einstein 
Medical Center, Germantown Hospital and Community Health 
Services, MossRehab, Willowcrest (a center for subacute care), 
Belmont Behavioral Health, and a number of outpatient and 
satellite locations. Einstein also operates a primary care 
network, Einstein Neighborhood Healthcare. 
Frankford has campuses in the Frankford and Torresdale 
sections of Philadelphia and in Bucks County. 
Thomas Jefferson University, which is composed of Jefferson 
Medical College, the College of Graduate Studies, and the 
College of Health Professions, is the primary academic affiliate 
of the Jefferson Health System. An Education and Research 
Committee, chaired by the dean of the medical college, advises 
the JHS board on academic and research activities. The 
President of Thomas Jefferson University is the Chairman of 
the Board of the Jefferson Health System. 
JHS's mission is "To improve the quality of life by providing 
comprehensive, cost effective, state-of-the-art health services for 
defined populations; to be actively involved in education in 
clinical practice; and to encourage research related to the 
advancement of health care delivery." 
The university and the health system, while they are separate 
entities, are partners, recognizing the symbiotic nature of 
patient care, education, and research. They share an emphasis 
on what is best for the patient, and they rely on each other for 
their mutual success. 
Community based and decentralized, JHS is based on a model of 
collegiality and consensus. Douglas S. Peters, the system's 
President and CEO, emphasizes that "Every decision is centered 
on the ability of each member institution to continue to provide 
excellent health care in its respective community. It is this 
excellence and sensitivity, 'the human touch,' that sets JHS apart 
and makes our member institutions so well regarded." 
In addition to its full members, JHS has forged strategic 
alliances with Christiana Care Health System in Wilmington, 
Delaware, Pottstown Memorial Medical Center, Riddle 
Memorial Hospital, Underwood Memorial Hospital in 
Woodbury, New Jersey, and AtlantiCARE in Atlantic City, New 
Jersey. JHS has strong ties with duPont Hospital for Children in 
Wilmington. 
This breadth enables the Jefferson Health System to offer health 
care from infancy to late adulthood, across a major geographic 
area. Besides acute care, it is a market leader in behavioral 
health, rehabilitation, home health, senior services, and 
alternative (integrative) medicine. 
Operating costs can be streamlined when the institutions work 
together. There are 2,800 hospital beds and a medical staff of 
3,000 in JHS member institutions. Substantial money is being 
saved by rethinking areas such as laundry services, energy use, a 
joint billing system, and integrated clinical information 
software. At present, the Jefferson Health System and Thomas 
Jefferson University are both in solid financial positions, and 
their bond issues are given unusually high ratings. 
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Jefferson Health System also has additional ambulatory sites and satellites across the Delaware Valley. 
Conveniently located throughout the region are satellites of the 
Jefferson Health System. Some of the ambulatory care facilities 
are almost like hospitals without inpatient beds; others are 
smaller, like extensions of physicians' offices. Spacious facilities 
have been opened in Upper Providence, Exton, Broomall, and 
Voorhees, New Jersey. 
More than 600 primary care physicians are associated with 
r JHS, in addition to numerous medical and surgical specialists. 
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Jefferson HealthCARE is the name for an expanding network 
of conveniently located doctors including Great Valley Health 
physicians, JeffCARE physicians, and duPont Hospital for 
Children physicians. JeffCARE is a physician-hospital organi-
zation that brings together Jefferson Medical College's full-time 
faculty (in the Jefferson Faculty Foundation), its volunteer 
faculty, and the hospital. 
JHS maintains an informative Website at 
wwwjeffersonhealth.org 
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Education in the Jefferson Health System, Now and Tomorrow 
J
efferson Medical College has, over many years, nurtured collabo-
rative relationships with its affiliated teaching hospitals, which have 
provided outstanding opportunities for students, residents, and fellows 
to provide care to patients and learn clinical skills. Much of the success 
of the clinical curriculum is due to the contributions of faculty at these 
affiliated hospitals. The trust and shared values that have evolved have 
been expanded into a formal relationship with a number of our 
educational partners called the Jefferson Health System. (As shown in 
the illustration at right, the JHS teaching hospitals are a subset of the 
affiliated hospitals of Jefferson Medical College.) 
The leadership of Thomas Jefferson University and Main Line Health, 
in crafting the beginning of the Jefferson Health System, envisioned a 
coordinated, collaborative educational and research environment. They 
wished to enhance the national leadership position of Thomas Jefferson 
University, and at the same time enhance the member teaching 
hospitals. The rudiments of a structure for achieving this vision were 
outlined in a Master Academic Agreement (which obligates members of 
the Jefferson Health System to function in a coordinated fashion, under 
the aegis of the Education and Research Committee of the JHS Board of 
Trustees). Over the first 18 months of operation, the Education and 
Research Committee refined the vision, mission, guiding principles, 
and strategic goals of the education and research efforts of system 
members. 
It soon became clear that the relationships between the participating 
institutions required a more formal arrangement if our vision of 
excellence was to be realized. The range of integration of educational 
programs spanned the extremes, from full integration and centralized 
coordination by the medical college (in the case of undergraduate 
medical education programs and some graduate medical education 
programs), to independent parallel programs which cooperated in 
certain ventures but maintained a high degree of local control (in the 
case of certain graduate medical education programs and nursing 
schools). 
Health care's reimbursement structures are rapidly changing. 
Increasing local pressures on the patient mix of individual institutions, 
the movement of patients to the outpatient environment, the pressure 
placed on faculty for productivity, all led to the conclusion that our 
institutions must collaborate in order to maintain the quality of clinical 
education. 
Further, the national trend is toward enhanced coordination of the 
continuum of medical and allied health professional education. To 
accomplish this, and to cope with ever-higher accreditation standards, 
we need a centralized approach. 
Finally, the recent changes in Medicare reimbursement for graduate 
medical education (in the Balanced Budget Act of 1997) require certain 
responses from us, in order for us to continue to receive 
reimbursement as programs collaborate and residents move from 
institution to institution. The legislation altered certain basic assump- 
Jefferson Medical College Affiliated Teaching Institutions 
Thomas Jefferson University Hospital 
(principal teaching hospital). 
Methodist Hospitala,b 
The Lankenau Hospital. 
Bryn Mawr Hospital. 
Bryn Mawr Rehabilitation Hospital. 
DuPont Hospital for Children 
The Wilmington Veterans Administration Hospital 
Christiana Care Health System 
Episcopal Hospital 
Albert Einstein Healthcare Network. 
Wills Eye Hospitald 
Magee Rehabilitation Hospital. 
Latrobe Hospital 
Geisinger Health System 
The Mercy Hospital of Pittsburgh 
St. Francis Medical Center, Pittsburgh 
Lehigh Valley Medical Center 
Atlantic City Medical Center 
West Jersey Health System 
a—Member, Jefferson Health System 
b—Owned by Thomas Jefferson University Hospital 
c—Alliance relationship with Jefferson Health System in place or under negotiation 
d—Purchase by Thomas Jefferson University under negotiation 
Affiliated Teaching Institutions 
Jefferson Health System 
Teaching Institutions 
Non-teaching Institutions 
in Jefferson Health System 
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Lions. For instance, it had been presumed that integration of residents 
from one program into the university program (with resultant rotation 
of residents to the participating teaching hospital) would approximate 
a revenue neutral exchange (the university hospital would increase its 
direct GME reimbursement [DGME] count, and the teaching hospital 
would maintain its indirect GME reimbursement [IGME] count while 
decreasing the DGME count and not incur the costs of employment of 
the residents). But this is no longer possible. Each institution had its 
DGME and IGME count and ratio capped at the December 1996 level. 
This precludes the university from merely increasing its total number 
of trainees while the collaborating teaching hospital decreases its 
number. In order to accomplish such a movement of positions while 
maintaining reimbursement for the number of trainees within the 
family of institutions, a Joint Entity Application must be filed, or 
the sponsoring institution for the programs must become a consortium. 
These factors, coupled with the desire of the leadership to bring 
together the farflung knowledge and expertise within the system, led 
the members of JHS to formally create a Consortium for Medical 
Education and Research. 
Certain principles form its basis. These have been endorsed by the 
Education and Research Committee: 
• The institutions agree to a model of shared decision making. They 
adopt a structure and process which builds consensus regarding key 
decisions, and these collective decisions will be binding. 
Factors Fostering Formation of an Educational Consortium 
• Diversity of clinical experience 
• Heightened curricular demands of ACGME 
• Opportunity to enhance the clinical educational experience for all trainees 
• Opportunity to mold the continuum of education, not only within profes-
sional disciplines (medicine, nursing), but also to promote multidisciplinary 
training environments 
• Difficulty in recruitment of qualified candidates from U.S. medical schools 
• Opportunity to bring the "university" designation to all programs in the 
System 
• Ability to respond to societal needs with curricular and manpower adjust-
ments, due to breadth of service area, size of programs, and broader view 
• Opportunities for economy of scale in certain programs or disciplines 
• Opportunity for maximization of GME revenue stream as residency 
programs integrate and share clinical resources 
• Opportunity to have educational programs as a hallmark of JHS, enhancing 
system differentiation from other health systems 
• Certain articulated powers will be reserved to the individual 
institution, while certain powers will be delegated to the consortium. 
• Integration will be fostered and supported. 
• All participants in the consortium will be governed by the Master 
Academic Agreement, or agreements that reference it. 
• The structure will recognize the central role of the university in 
education. 
• The educational and research efforts will be linked to community 
needs. 
This type of consortium is classified as a Mixed Model,' having varying 
degrees of integration. The relationship between the university and the 
teaching hospitals is one of shared responsibility as opposed to an 
autocratic, hierarchical system with unilateral control by the university. 
All members of the consortium work together to improve the quality of 
instruction and research systemwide. 
The system's founding members and the university's leaders are now 
working out the administrative details of this collaborative relationship. 
As we navigate the difficult path into the next century, our goal is 
continued excellence in undergraduate and graduate medical education 
for the next generation of Jeffersonians. 
1—AAMC-UCSF Study of Academic Consortia. Association of American Medical Colleges. 
Washington, DC. January 1997. 
Factors Hindering Consortium Formation 
• Institutional history and identity 
• Willingness to develop (redundant) services/capacity rather than collaborate 
• Potential loss of the creativity that was fostered by diversity of programs, 
program directors, and unique educational sites 
• Concern over loss of professional identity 
• Ability to identify well prepared international graduates 
• Fear of academic and fiscal control of all educational programs by the 
university 
• Societal need for curricular and manpower modification often conflicts with 
the needs and desires of individuals 
• Possible increase in costs due to technology requirements and administrative 
costs of more complex multi-institutional programs 
• Fear of loss of control over reimbursement, not only for GME costs, but also 
for portion of IGME dollars which support care of the indigent, technology 
mix, and acuity of illness of teaching hospitals 
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Student Education at Jefferson under Managed Care 
medical education is facing the reality of managed care. Pandora's box has been opened, and we must respond. 
Medicine did not respond collectively three decades ago when Paul 
Elwood, M.D. first suggested the HMO concept in the early 1970s. 
Those who paid for health care—employers and government—did 
respond and insisted that the cost of health care was too high and 
rising too rapidly. And the for-profit HMO industry did listen. 
There are two major reasons why medical education must keep 
abreast. Firstly, our graduates must practice in the new 
environment where the rules are different: they have to understand 
these rules and how to practice quality medicine within them. And 
they have to learn about managing care, not just managed care. If 
physicians are to continue to be the advocate for the patient, they 
must be the leaders in delivering quality care in a cost effective 
manner. 
Jefferson Medical College is responding. Susan L. Rattner, M.D., 
Associate Dean for Undergraduate Medical Education, points out 
that "students are the agents of change." Altering our attitudes 
about managed care, and giving the students the mindset and tools 
to manage care, are the challenges. 
schools that responded, Jefferson was one of only 18 that qualified 
for the next step, a site visit, and Jefferson received partial funding. 
The effort of developing the proposal refined our thinking on how 
to incorporate managed care into the curriculum. 
Furthermore, Jefferson Medical College was awarded the contract 
for performing the data analysis and tracking the progress of the 
UME-21 Project. This award recognized Jefferson's leadership, 
under Dean Joseph S. Gonnella, M.D., in evaluating and measuring 
results of medical education. Jon J. Veloski of Jefferson's Center for 
Research in Medical Education and Health Care was named the 
principal investigator. 
A concept central to the UME-21 Project is that good medicine 
• is cost effective. At the same time, it 
• is evidence based (treatment is based on scientifically applied 
standards), 
• stresses prevention and teamwork, 
• uses system based care, 
• evaluates the epidemiology of patient populations, and 
• involves the patient in decision making. 
David Nash, M.D., M.B.A., Associate Dean for 
Health Policy and Clinical Outcomes, has been 
instrumental in bringing managed care into the 
curriculum. First year medical students are 
given a health policy course during "Jan Plan." 
Additional classes include population medicine 
and biostatistics in the first year, and public 
health and epidemiology in the second year. 
At-risk populations are evaluated. But these 
have been general courses, and it is only in the 
past two years that Jefferson's involvement in 
two other programs is focusing our attention on 
the educational requirements of managed care. 
Jefferson responded to a request for proposals 
from the UME-21 Project (Undergraduate 
Medical Education for the 21st Century), a 
collaborative initiative of a consortium of 
primary care organizations. Of the 50 medical Jefferson's campus at the heart of Center City (aerial view from the east) 
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Jefferson's involvement in the 
project has led us to introduce 
specific educational interventions. 
Starting in July 1998, third year 
students rotating through 
clerkships in internal medicine, 
pediatrics, and family medicine 
were required to read the Managed 
Care Manuals prepared by Dr. 
Nash and his staff. These describe 
the key principles and definitions 
of managed care; how to maintain 	 Stanton N. Smullens '61, Lina M. 
autonomy while using clinical 
practice guidelines; and how to implement cost effectiveness 
principles while maintaining quality under Medicare, Medicaid, and 
the managed care environment. 
The other intervention has been the development of a mini-
clerkship in the fourth year. Medical students are required during 
their subinternship rotations in the Philadelphia area to rotate 
through JeffCARE. This consists of a one-week course given in 
JeffCARE, the physician hospital organization of Thomas Jefferson 
University Hospital. JeffCARE is a not-for-profit corporation that 
brings together the full-time faculty (in the Jefferson Faculty 
Foundation), the volunteer faculty, and the hospital. It is an organi-
zation designed to function in the world of managed care; it 
currently partners with Aetna U.S. Healthcare under a full risk 
contract serving approximately 30,000 non-Medicare individuals. 
The course, led by Jeffrey L. Lenow, M.D, J.D., JeffCARE's Medical 
Director, is given every six weeks to a new group of students and 
covers areas such as 
• the work of a medical director, 
• contracting with payor organizations, 
• ambulatory case management, 
• data analysis, and 
• finances regarding managed care. 
The students also pay site visits to physician offices and become 
familiar with the mechanics of a managed care organization. The 
course began in January 1999 and will eventually involve approxi-
mately half the class who spend their fourth year at Jefferson. 
Pre- and post-testing will evaluate the students' understanding of 
principles and their attitude toward managed care in general. 
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O'Brien '91, James S. Harrop Jr. '95 
A timely addition to Jefferson's undergraduate offerings is a joint 
M.D./M.B.A. offered in conjunction with Widener University. 
Currently nine students are enrolled in the five-year program, 
initiated five years ago, and the first two graduate in May 1999. 
Before being eligible for the program, applicants must be admitted 
to Jefferson Medical College, and then to Widener. They spend the 
summer at Widener before formally starting at JMC. Two years are 
spent at JMC with the intervening summer at Widener. The third 
year is entirely at Widener, then the students return to spend their 
last two years in medical school. Some evening work is also 
involved. 
This program reflects the growing number of M.D.s who are 
obtaining M.B.A.s. Physicians are adaptable, and they are beginning 
to take a leadership role in the business side of medicine, 
a necessary role in protecting the interests of the patient. 
Another influential project, again involving Dr. Nash as an 
associate director, is Jefferson's participation in Partnerships for 
Quality Education, a collaboration between academic medicine and 
managed care organizations to fund learning experiences in 
managed care. 
In a variety of ways, Jefferson's instructional programs are 
responding to the new realities of managed care. Although it is too 
late to put the lid back on Pandora's box, as in the myth, 
hope remains inside. Our students are the future of 
superior care. 
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A Student's Perspective 
How Much Has Changed? 
by Jennifer King '01 
S 
ii 
	
	 o, how is second year treating you?" the elderly alumnus 
asked over hors d'oeuvres in the faculty lounge. 
Already edgy because I'd forgone two precious hours of prime 
study time to attend the alumni executive board meeting, I 
began, "I'm finding it a lot tougher than last year . . ." 
"I'm tired of hearing sophomores complaining all the time about 
school. It's not any harder today than it was 50 years ago. I don't 
know why they're so soft." 
Though I presume the gentleman had heard the complaints of 
dozens of sophomores over the years, the exchange left me 
fuming. When he graduated five decades ago, they didn't even 
know what DNA was, let alone the function of zinc fingers in 
gene transcription. And what drugs did he have to memorize in 
his pharmacology course? Aspirin, digitalis, and quinine? 
Certainly not the hundreds of drugs that I was struggling to 
store in my long term memory. Though no new muscles or 
arteries have been discovered since he was in medical school, 
surely the brain was a black box to his class—not the intricate 
meshwork of minutely described pathways and reflex arcs that 
Dr. George Brainard, Professor of Neurology, had held me 
responsible for, just six months before . . . 
Of course, I eventually realized that this was an argument I 
couldn't win. I admitted that this elderly doctor must possess at 
least a passing understanding of the information I was being 
tested on. However, he had had 50 years to assimilate it, 
whereas my classmates and I had a mere two years to master all 
this material! 
I was left wondering: had medical school changed over the last 50 
years? 
A conversation with Henry A. Shenkin '39, former Professor and 
Director of the Neurosurgery Division at the Medical College of 
Pennsylvania, revealed that the curriculum of medical school, as 
far as courses go, has not changed much at all. He and his 
classmates sat through lectures in physiology, bacteriology, 
pathology, and biochemistry. "We had anatomy every afternoon 
for three hours for a year," Shenkin recalled. But bones and 
vessels weren't the only things studied on the balcony of the 
storied Baugh Institute. "That's where I learned to smoke!" he 
added conspiratorily. 
In the intervening years, Jefferson's anatomy course was pared 
down to a four and one-half month endeavor. After years of 
exposure to residents who had taken this modern "abbreviated" 
course, Dr. Shenkin can't recall them knowing any less about 
anatomy than his generation. 
Paul Weinberg '69, Associate Professor of Pediatrics and 
Radiology at the University of Pennsylvania, didn't mince words. 
"I really doubt that medical students work any harder than we did 
30 years ago. They're just working on different things." He 
explained that today students don't spend six months in the 
anatomy lab learning the body in the minute detail that was 
required of him and his contemporaries. While students of 
yesteryear could not be expected to know the biochemical 
reactions carried out within mitochondria, they were expected to 
know muscle insertions and anatomy in more detail than current 
students are. 
Barbara Atkinson '74, former Annenberg Dean of MCP-
Hahnemann School of Medicine and previously Chair of 
Pathology at Medical College of Pennsylvania, agrees. "We 
learned much more anatomy back then. It is very superficial 
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Drs. Shenkin, Atkinson, Weinberg, Plumb 
now." Atkinson, whose 
husband graduated from Jeff 
in '64, mentioned that she 
was unable to use any of his 
textbooks when she matricu-
lated at Jeff. In the 
intervening years, a profes-
sional movement away from the Latin terms for structures to their 
more precise anatomical descriptors had made his textbooks 
obsolete. Additionally, great leaps had been made in research, 
necessitating extensive rewrites of biochemical texts and instruc-
tional materials. In those days, Atkinson related, biochemistry 
was not even taught in college, although she was exposed to it in 
graduate school. 
In retrospect, Shenkin believes that the yearlong course went into 
excessive detail. "I think we did too much anatomy!" he mused. 
Though the time spent on various topics has changed, only a few 
courses have been added to the Jefferson curriculum in the last 50 
years. One of these is Doctors in Health and Illness, offered 
during freshman year. This yearlong class satisfies the behavioral 
science requirement of the medical curriculum but also covers 
topics deemed essential to the development of the successful 
medical student. James D. Plumb '74, Director of Education in the 
Department of Family Medicine and co-director of the DHI 
course, hopes that it will help to remedy the disconnect between 
the material students learn first year and how to apply it later in 
their clinical years. "Clinical correlations" have been a major 
theme in curriculum refinements in the past decade. 
But in the last 25 years, Plumb remarked, "I don't think medical 
education has changed very much in essence." "Even though the 
molecular detail down to the gene was not known, there was still 
plenty to learn," Atkinson assured me. 
And even more for 
graduates of the seventies to 
learn since then, I believe. 
Whereas we learn the 
language of breakthrough 
science in the lecture hall, 
Atkinson and her contem-
poraries have to keep up on their own, via CME courses and 
personal resourcefulness. It's something we current students will 
have to do soon enough. 
currently the required reading lists that accompany syllabi usually include some computer-based learning item, be it a 
CD or recommended Website. Weinberg lauds the new instruc-
tional materials saying, "They're useful in preparing presentations. 
Now it takes hours instead of days. And you can visualize 
anatomy (from a 3-D reconstruction of an MRI) and do it in a 
reasonable amount of time." But, he admits, the technology has 
not yet been exploited to its full potential. 
As students we have come to learn that the available technology is 
not necessarily worthwhile. Moreover, though we have more 
learning materials available to us replete with more bells and 
whistles, we don't have any more time in the day to review them. 
For example, a wealth of informative sources is available for 
pathology. Students can run question and answer sessions on the 
computers in the library, review slides on the Internet, obtain 
outlines from the pathology Web page, consult back notes, peruse 
class notes obtained from the note service, highlight prewritten 
student outlines of the textbook, and, as always, refer to the text. 
However, sometimes technology can be our downfall. Answers to 
the Q and A are by no means reliable. The available on-line 
outlines are incomplete. The prewritten notes refer to an outdated 
edition of the text. A wealth of information does not a successful 
medical student make. 
continued on page 30 
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"Now," muses Weinberg, "there's more stuff out there and it's not 
all good. Accessible, yes. But there's more garbage to weed 
through." 
However, technology has certainly spared students some of the 
more undesirable aspects rof medical school. During Atkinson's 
physiology course, student had to perform unsettling experiments 
on dogs in lab. Today students view videos or computer simula-
tions available in the library computer learning facility, which 
sufficiently communicate the lesson without sacrificing the animal. 
Technology is intrinsically tied to medicine. And, though Dr. 
Atkinson fears the movement from glass slides to CDs is not a 
good one, the Jefferson faculty takes great pains to ensure that 
students are exposed to recent and useful technologies. The 
informatics course offered during "January plan" exposes every 
freshman student to on-line medical search services, like Medline. 
In comparison, Atkinson was first exposed to Medline during her 
residency. "Before that," she laughed, "we had to use a real card 
index. It was much harder to get information, much harder." 
Technology in the form of email is married to the modern 
Jefferson medical student's very existence: Testing sites and times 
are emailed to the class by staff secretaries. Notification of correc-
tions to scribed notes and exams occurs almost exclusively 
electronically. Grades are disseminated by email. The location of 
the post-exam party is posted on email. 
Plumb knows firsthand that technology has revolutionized student 
rotations. Medical students can now make study arrangements 
around the globe via the Internet. "The world has shrunk," he 
says. 
Pioneering medical technologies are presented in the lecture hall 
on a regular, if not daily, basis. For example, the TIPS 
(transjugular intrahepatic portosystemic shunt) procedure was 
mentioned briefly in freshman anatomy and covered in detail later 
in the liver section of the sophomore Introduction to Clinical 
Medicine course. Physicians lecture on invasive radiologic 
techniques and cardiac catheterizations—state of the art 
procedures that we will see on the floors as third and fourth year 
students. When Atkinson was a resident, the technique of fine 
needle aspiration was burgeoning—and what frankly attracted her 
to her specialty in cytopathology. 
rr
iere's one profound difference between how we react to and 
_ deploy new technologies, and how Weinberg's generation did 
in the seventies. Even in the sophomore classroom we are 
constantly reminded of the cost and reimbursement considera-
tions for tests and procedures. Such cost consciousness never 
entered the equation for Weinberg until internship and residency. 
"Back then, x-rays and electrolytes with proteins (a basic blood 
chemistry panel) were major decisions," according to Weinberg. 
Today they are routine. "Now, MRI and CT scans are the big 
bucks issues," he says. 
Cost to the national pocketbook is a common theme in the ICM 
course. In the pulmonary section alone, at least two lecturers 
referenced costs associated with certain conditions. Dr. James 
Fish priced the annual cost of treating asthma in the United States 
in 1990 at $7 billion. During her lifetime, the average female 
smoker spends $55,434 on cigarettes alone, according to Frank 
Leone PUD'97. 
Cost is not the only topic that receives a more thorough treatment 
now. The role of insurance companies, lawyers, and HMOs are 
important factors impinging on the livelihood of physicians. So 
much so, that current students hear the extensive reflections of 
Dr. David Nash, Associate Dean for Health Policy, during the 
health policy course offered to freshman students in "Jan plan." 
Additionally, the law and medicine course in the sophomore 
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"December plan" provides a 
basic overview of the 
process of filing a suit and 
malpractice considerations. 
inconceivable that I could 
care for patients without a 
team that I trust," he says 
plainly. 
The alumni I've spoken to had minimal, if any, exposure to these 
topics during their medical school tenure. Now, Weinberg notes, 
"Half the time at seminars and professional meetings, doctors are 
talking about being wronged by insurance companies and 
lawyers." As a student, he recalls discussing law and medicine 
only superficially and never discussing suits in particular. The 
one thing they were taught, he says, was that having a "good 
rapport" with patients helped to prevent these things. 
The same advice is dispensed to current medical students, but so 
are more concrete rules. In his sophomore seminar Personal 
Problems of Physicians, Dr. Robert Brent, Distinguished Professor 
of Pediatrics, gives practical warnings and solid advice about what 
to do when (not if) you're sued, from handling the very real 
psychological impact to managing your clinical practice around 
the issue. 
1 - n recent decades the role of the physician has changed from 
one of unquestioned paternalism to partner or orchestrator of 
health care professions like home care nurses or physical 
therapists. In a move to reinforce the model of team-oriented 
health care, the Department of Nursing and the medical college 
hold a joint training seminar in the fall of freshman year on 
handwashing technique, a major factor in epidemiology. 
JeffHOPE, the award winning community service program, also 
serves as a vehicle for joint ventures as nursing students, medical 
students, and physical and occupational therapists work side by 
side at the ACTS clinic. 
Plumb applauds this fostering of collaborative effort and 
underscores its value in the current patient care climate. "It is 
Jefferson's medical school curriculum continues to expand to encompass research breakthroughs and evolving patient care 
concerns. Though all of the alumni I interviewed agree their 
medical education was first rate, they offer a sobering truth: that 
90 percent of what we learn we'll never recall or never use. 
"Factual information is NOT what I got out of medical school," 
Weinberg offers. "I learned how to stretch my physical endurance 
and my attention span—learned how to assimilate new 
information quickly. The specifics you're learning now will be 
passé by the time you do your residencies." 
It is a discouraging thought indeed for those of us in the throes of 
the three week testing schedule of second year. 
He continues, "Most of what I learned and use now, I learned 
during post-medical school training. Medical school is a time to 
learn an approach—training yourself to amass and organize 
knowledge in a limited time. How much do you actually use? A 
relatively small amount. But you need to train yourself to jump 
daunting hurdles and to constantly keep abreast of new develop-
ments on the horizon." 
Atkinson echoes his sentiment, "The most important thing to 
teach medical students is to be lifelong learners." 
For Plumb, the important lessons of medical school are more 
spiritual in nature. In his mind, medical schools have always 
instilled in students a healthy work ethic. But "the job of medical 
faculty and school is to foster compassion and humility. Practicing 
medicine is a blessing, not a right." 
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"The first- and second-year students present to physicians and write up reports, 
and the third- and fourth-year students get a chance to teach what they've learned." 
Left to right, Mike Padula '00, Jeff Dassel '02, Tonya Kolodziejski '01, Chuck 
McClure '97, Glenn Cannon '00, Chris Shale '02. 
At JeffHOPE, Learning and Caring Go Hand in Hand 
/ t started out as a routine night at JeffHOPE's Gateway clinic—the usual upper respiratory infections, hypertension, asthma, and skin 
infections, as homeless patients drifted in from the streets of Center 
City Philadelphia and nearby shelters. 
The Gateway Service Center is a stark cinderblock structure on a dead-
end block of Hamilton Street that passes under the abandoned, 
brooding Reading Railroad trestle. The persuasive hand of Philadelphia 
Mayor Ed Rendell induced local unions to contribute their time to the 
rehabilitation of a warehouse, and the city contracted with the 
Salvation Army to run the homeless shelter. 
In the second bed of the last row, a 53-year-old male has vomited a 
huge knotted pile of blood onto his uncovered mattress. Sharma asks 
him routine questions which he answers directly, lucidly. Lightheaded? 
Yes. Dizzy? Yes. He has a sharp, intermittent belly pain but no chest 
pain. 
The patient adds that he hasn't had a bout like this since 1987, when 
he was pulled into the ER at Pennsylvania Hospital after drinking a half 
gallon of vodka a day for six months. He drinks a little now, "on and 
off." He hasn't had anything to eat for three days. Any alcohol today? 
"Oh, no!" He seems appalled at the thought of tossing anything like 
that into his ruined interior. 
Inside, the cinder blocks are textured and 
colored, but it's still institutional and bare-
bones. The one anomaly is the back wall of 
the JeffHOPE clinic student room, where 
massive, dark stones sit awaiting the call of 
Torquemada—the warehouse was built out 
directly from the old Reading trestle. 
However, any macabre spirit has fled 
before the bright good humor of the seven 
or eight JeffHOPE volunteers clustered in 
the room with Chuck McClure '97, the 
Bryn Mawr Hospital resident who is acting 
as fill-in volunteer physician for tonight's 
clinic. 
McClure has just mentioned that the clinic 
handles an occasional ER case when word 
comes through of an emergency upstairs. 
Anil Sharma, M.D., a resident in medicine 
at Thomas Jefferson University Hospital, 
hurries up the enclosed stairwell to the 
second floor, where beds for 70 homeless 
residents are clustered in corrals separated 
by two-foot cinderblock dividers. 
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Sharma asks a student volunteer to call an ambulance. His tentative 
diagnosis is a bleeding ulcer. The patient sounds relieved to be going to 
the ER. 
The Gateway Center and the clinic set up by JeffHOPE (Jefferson Health, 
Opportunities, Prevention, Education) opened together on November 
11, 1993, the day the city began its sweep of the subway concourses 
which had become the camping ground of hundreds of the Philadelphia 
homeless population, many with 
chronic health problems such as 
tuberculosis, AIDS, and skin 
disease. 
Andrew Wilson, Gateway's 
volunteer and program coordi-
nator, remembers the raw Jefferson student volunteers who "triaged the 
clients as they came through the door" while men filled the upstairs beds 
and spilled over onto makeshift cots in the large downstairs dayroom. 
JeffHOPE itself sprang in 1991 from a group of Jefferson medical 
students who approached James D. Plumb '74, then Assistant Professor 
of Family Medicine, asking what equipment they would need to open an 
office for the homeless. Plumb, a concerned pragmatist, asked them, 
"Are you sure your services are needed? Where are you going to work? 
What are you going to offer? These are complicated issues." 
To assess actual need, the students joined Plumb to canvass providers, 
such as the Salvation Army, which has been active in homeless care for 
100 years. "The first response we got," Plumb recalls, "was, `Now where 
has Jefferson been in all this?' 
"Since then, Jefferson has significantly increased its responsiveness to 
the community and partnerships with other organizations over the last 
six to eight years," Plumb says, largely through the efforts of the 
students who formed the core of JeffHOPE. 
One of the organizations they visited was Project HOME, run by Sister 
Mary Scullion, which had inherited a shelter for chronically homeless 
men begun at St. Columba's Church under the auspices of the Bethesda 
Health System Extends 
Public Health Outreach, 
With Plumb's Guidance 
Jim Plumb's dedication to community service stretches back two decades. In 
1980, after taking his M.D. and residency in family medicine at Jefferson and 
then joining the department, he received a federal grant to start a home visit 
program for some 200 patients. "We'd lose contact for a couple of months," he 
says, "and then they'd show up in the office and we would find out that they had 
been hospitalized in another institution. 
"It became clear that a lot of folks—particularly the elderly and those with 
disabilities—weren't able to make it to our office. There were too many 
variables: family members had to work and couldn't bring them, so they'd 
schedule an ambulance at $60 or $100 and end up in the local ER or getting 
admitted for hospitalization. 
"In the office, we'd see a snapshot, but a home visit would provide a video." He 
found cupboards full of unlabeled medicines and refrigerators full of junk food. 
He took note of elderly grandmothers taking care of young children and of the 
curled-up rugs an infirm patient might trip over. 
For eight years, Plumb made a side journey to a small family practice near his 
hometown in central Pennsylvania. He found himself enmeshed in a variety of 
nontraditional activities—joining drug and alcohol planning councils, taking a 
seat on county boards, advising civic associations and personnel directors on 
the health care programs they should offer. 
"During my education, particularly at Jefferson, I had a physician-centered 
notion of care, that the doctor always knew what was best. But that's just not 
so. We're becoming less paternalistic." His experience in the expanded role of 
community medicine made him the ideal conduit for student public health 
concerns when he returned to Jefferson in 1990. 
This year, Plumb was named Associate Vice President for Community Service 
and Public Health of the Jefferson Health System. The system supports a variety 
of community services: in suburban Chester County, volunteers serve migrant 
workers in the mushroom industry; throughout the Delaware Valley, a "congre-
gational nurse" program provides health education to some 30 churches 
("people can come up to a nurse after services, and she's able to translate the 
jargon we've been using into real life terms"); suburban school districts join 
with the system in health education partnerships. 
The health system provides both funds and volunteers to healthy-community 
groups in which "folks from all walks of life come together and share common 
issues, from well-being to schools," says Plumb. "We convene groups, we 
catalyze groups, we provide technical support and personnel, we link faculty 
with particular interests to communities—we act as a clearinghouse for 
outreach in its broadest sense. 
"A successful health system is measured in many ways. One of them is its 
contribution to public health." 
90 percent of 
first-year students 
volunteer for 
JeffFIOPE 
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Socrates Vozoris '00 and Michael Platt '02 
take a patient's history. 
Project. Keeping the name, Project HOME moved St. Columba's to a 
pair of twin houses in Powelton Village, north of Drexel University. 
Sister Mary asked if Jefferson would be interested in providing a clinic 
at St. Columba's. "She recognized that the these were special students," 
says Plumb. "They had a passion and their altruism shone." 
The students presented a broad proposal for community medical ser-
vices to the Jefferson administration and received probationary approval 
in October 1992. Over 100 student volunteers signed on for orientation. 
The St. Columba's clinic opened in January 1993, and JeffHOPE 
received full approval nine months later as a noncredit elective. 
Lara Carson-Weinstein '95, a new member of the Family Medicine 
faculty at Jefferson, was a second-year student at the time, one of the 
seven founders of JeffHOPE. She served as St. Columba's project 
Like JeffHOPE, Bridging the Gaps introduces students to a 
broad spectrum of patients not normally seen in a medical 
school or graduate school context. Bridging the Gaps, a 
seven-week summer urban-health internship program, 
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director from 1992 to 1995. As she recalls, "It was lucky that the 
original students had different areas of expertise and interest. Some were 
adept at working with the administration, some at working with 
students, but the biggest thing for me was meeting the homeless and 
breaking down the barriers to provide health care services." 
But the road to altruism proved a bumpy one. Many in the St. Columba's 
population of 30 older men suffered from mental illness and substance 
abuse. They had been living on the streets for 10 years and had little 
trust of the medical establishment. Adds Carson-Weinstein, "We 
brought paint and equipment and fixed up the place, but no one would 
come up to the clinic. So we went downstairs and had dinner with them 
and played cards for six months before the first patient came to see us." 
In addition to St. Columba's and Gateway, three other community 
clinics now stand under the JeffHOPE umbrella. Women of Change, 
opened by Project HOME in 1996 on the edge of Center City, provides 
long-term housing for women with chronic substance abuse and/or 
psychiatric problems. JeffHOPE's biweekly clinic there places heavy 
stress on education and preventive medicine. 
involves all four medical schools in the Philadelphia area, 
bringing the competing schools together under a common 
tent. Its community-based, interdisciplinary approach 
involves students from medicine, nursing, occupational 
therapy, physical therapy, dentistry, social work, and law. 
Projects developed by Bridging the Gaps include tailoring 
educational materials to the literacy level of patient groups, 
assessing the nutritional requirements of the homebound 
elderly, aiding recovering drug-addicted mothers and their 
children, and counseling for teen mothers. 
Many students maintain contact with the organizations they 
served throughout the year, lending additional volunteer 
support as needed. They also summarize their experience 
through posters which are displayed at a citywide Bridging 
the Gaps symposium. 
At left, students work with a child with disabilities from an 
underserved neighborhood. Robert Nero!, photo 
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to navigate them through the social services system: drug and alcohol 
rehab, mental health, housing, legal services, medical insurance." 
The advocates also meet with Jefferson psychologist Stephen Weinstein, 
Ph.D. and two psychiatrists to talk over cases and learn more about the 
nature and effects of street drugs. "It's a tough job with a high burnout 
rate," says Prosseda, "but there's always a handful of students who 
continue all four years." 
Other health professions work with medical students at 
JeffHOPE: here, a physical therapy student examines a patient 
at the shelter. 
Operating from a van in North Philadelphia, an earlier private program, 
Prevention Point Philadelphia, provides needle exchanges for chronic 
drug users. Student volunteers at Prevention Point asked JeffHOPE to 
add a medical clinic to treat such conditions as abscesses developing 
from IV drug use. Funded by a $40,000 grant from the Soros 
Foundation, JeffHOPE now provides medical services every Saturday 
morning during needle exchanges. Chuck McClure notes that the 
patients range far beyond the North Philly neighborhood: "They come 
from the suburbs and as far as Reading with shopping bags full of 
needles, 100 to 150 at a time." 
The most recent addition to JeffHOPE, ACTS I, is a private shelter run 
by the Acts of the Apostles Church, providing housing for up to 160 
women and 60 children who are homeless from a wide range of causes 
such as house fires, domestic abuse, and substance abuse. The Jefferson 
nursing school has taken the lead at ACTS I, providing health 
education that has recently been augmented by a JeffHOPE clinic 
concentrating on obstetrics, gynecological exams, and prenatal care. 
Several volunteers serve as patient advocates under JeffHOPE. Julie 
Prosseda '99, who will be taking her residency in family medicine at 
Jefferson, served as a patient advocate at both Prevention Point and 
Gateway: "When the medical clinic started at Gateway, the students felt 
that the patients' social needs were not being met, so several of them 
started a social services arm. It's a lot of listening, one on one. We try 
At ACTS I, a student recently served as birthing coach and helped deliver 
the first JeffHOPE baby. 
JeffHOPE is a fully student-run organization, with Jim Plumb acting as a 
mostly "hands off" advisor. A 35-student steering committee includes 
three directors and various coordinators who assign both student and 
physician volunteers as needed. 
The Gateway Center is a model of cooperation among volunteers from 
across the Jefferson campus. Students from the College of Health 
Professions staff clinics for both occupational therapy, called Ways and 
Means, and physical therapy, under the rubric of Hands of Hope. Students 
from the School of Nursing provide a broad educational component. 
Typically at Gateway, the largest JeffHOPE project, the weekly Thursday 
night medical clinic is staffed by five teams, each comprising several first-
and second-year students, a nurse, and a third- or fourth-year team 
leader. (Because 80 to 90 percent of first-year students volunteer for 
JeffHOPE, each is assigned only two or three clinic visits a year.) The 
teams present to a volunteer attending physician, one of roughly 100 from 
Jefferson clinical departments. 
The clinic opens at 6:30 P.M. and usually finishes seeing patients by 10, 
though this can last until midnight in the high-demand winter months. It 
serves an average of 15 patients a night, male and female, Gateway 
residents and walk-ins. Patients sign up in the dayroom, which is also the 
triage site. The clinic itself, down a corridor, includes two private rooms 
and two cubicles where the lower-year students take medical and social 
histories. A pharmacy cabinet holds drugs donated by Jefferson and other 
area sources and materials for routine laboratory testing. 
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Gateway is a "low-demand shelter": its residents are not required to take a physical for 
admittance. However, the JeffHOPE Gateway clinic performs three or four physicals a week for 
admittance to shelters such as Horizon House, a drug and alcohol rehab center. (In addition to 
the male residential program, Gateway maintains a day program which serves up to 30,000 meals 
a month to any adult homeless person.) 
Volunteer coordinator Wilson notes that Gateway and Jefferson have collaborated on close to 
$1 million in grants for the "provision of services that most of the homeless never have a chance 
of getting." The latest feather in the JeffHOPE students' cap is a $40,000 Community Impact 
Award from SmithKline Beecham for their work at Gateway. The award money has been banked 
for equipment and drugs. 
The student volunteers, present and former, are pursuing a variety of career paths. McClure, a 
Stephen King lookalike who served as a JeffHOPE student director in 1997, wants to enter a 
family practice in or near Philadelphia—"urban family practice is picking up"—and stay 
involved in JeffHOPE. 
Michael Padula '00, student director at Prevention Point, is leaning toward pediatrics, buttressed 
by a firmer knowledge of "the barriers within a municipal or state system and the challenges 
people face in accessing health care." 
For Carson-Weinstein, a highlight of JeffHOPE was that "It allowed me to get out of the library 
and away from memorizing early in my medical school career, so I didn't lose my idealism about 
medicine. With the homeless, everything is stripped away; it's just you and them in their own 
environment, using your own skills." An added plus was getting to know fellow student 
volunteer Michael Weinstein '94, her future husband. 
Gateway student director Alex Metzger '00 hopes to upgrade JeffHOPE's triage system to include 
the physical therapy, occupational therapy, and nursing components, as well as medicine. "This 
program is great for everybody. The first- and second-year students get to present to physicians 
and write up reports, and the third- and fough-year students get a chance to teach what they've 
learned. And the patients learn that we really want to help them." 
Julie Prosseda sums up the JeffHOPE experience neatly: "We're trying to make a difference, in 
however small a way, week to week, client by client. I hope that we're creating a whole 
generation of health professionals who understand a population different from the one they came 
from. I've developed great relations with clients—they may or may not be better off, but they're 
still alive and happy to see me, and I'm happy to see them, to provide what they needed." '4 
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throughout the Country 
including Postgraduate Alumni, in Each State 
MONTANA 
21 
WYOMING 
13 
NORTH DAKOTA 
6 
MINNESOTA 
52 
SOUTH DAKOTA 
8 
RI55  
343 
O 
IOWA NEW 1,266 JERSEY 
DELAWARE 335 
MARYLAND4O5 
27 
NEBRASKA 
12 
COLORADO 
118 
KANSAS 
23 MISSOURI 57 
OKLAHOMA 
30 
NEW MEXICO 
49 
American Samoa: 2 
Puerto Rico: 33 
U.S. Virgin Islands: 4 
Total physicians graduated from Jefferson since its founding: 27,635 
Total postgraduate alumni trained at Jeff: 3,238 
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Outside U.S. 
Australia 1 
Bahamas 1 
Belize 1 
Bermuda 1 
Brazil 2 
Canada 18 
Chile 1 
China (Taiwan) 1 
Costa Rica 1 
France 1 
Gambia 1 
Germany 2 
Hong Kong 2 
India 3 
Israel 3 
Japan 2 
Jordan 1 
Malaysia 1 
Mexico 3 
Nepal 1 
New Zealand 3 
Peru 1 
Portugal 1 
Saudi Arabia 2 
South Korea 5 
Spain 3 
Switzerland 1 
Syria 1 
Thailand 8 
Trinidad and Tobago 1 
Turkey 2 
West Indies 1 
Total Abroad: 76 
"Jefferson has been very important to my family, 
and we want to help future generations of students 
benefit from the excellence of a Jefferson education." 
Michael Ellis '70 
v:or Michael Ellis and his family, a Jefferson education is a 
tradition dating back to the 1930s. Through the years, nine 
family members have attended Jefferson Medical College, and an 
uncle, Arthur First, was a longtime member of the faculty. 
Michael, who is an obstetrician/gynecologist in private practice, 
also notes that two of his three partners are alumni. 
"I was delighted that my son chose to attend Jefferson," Michael 
says. "When I compare my educational experience with his, I 
realize how much Jefferson's curriculum has evolved to prepare 
physicians for the increasing complexity of medicine today. And 
this challenge will only grow in the future." 
One challenge is the rising cost of medical education. Nearly 
three-quarters of Jefferson students receive financial aid. 
Moreover, tuition funds only part of the actual expense of medical 
education. Jefferson relies on private support to provide student 
aid and attract outstanding faculty. 
To help new generations benefit from a Jefferson education and 
honor Michael's grandparents, the Abraham M. and Rose Ellis 
Foundation, which is celebrating its 50th anniversary, recently 
endowed a scholarship fund with a gift of $50,000. Michael is 
trustee of the foundation, which plans to add to this fund every 
year until it becomes an endowed teaching fund. 
Clockwise, Richard Ellis '49 (seated at left), Alison Sharpe 
Avram '96, Jeffrey Ellis '98, and Michael Ellis '70 (seated). 
Not pictured: Stewart First '56. Richard, Alison, Jeffrey, 
Michael, and Stewart are cousins. The portrait depicts 
Michael's grandfather, Abraham Ellis. 
"My family and I wanted to make a gift that would help as many students as possible," Michael says. "The Ellis Fund is a wonderful 
way to honor our family's Jefferson tradition and help future generations create their own." 
A Gift to Jefferson—An Investment in the Future 
To learn how your gift can help Jefferson, please call Florence Zeller toll-free at 1-877-JEFF GIFT [1-877-533-34431. 
Philanthropy Helps Jefferson Achieve Excellence 
rr
e magnificent generosity of alumni, trustees, faculty, corpora-
tions, foundations, and other friends has been crucial to the 
success that Jefferson celebrates during this landmark 175th 
anniversary. 
Success in education is a partnership between the teachers and 
students. Support from alumni and friends enables the university to 
nourish this collaboration with financial and emotional incentives. 
a trust to benefit the medical college. Mrs. Samuel M. V. Hamilton, a 
university trustee, has established three professorships at Jefferson 
Medical College and has funded research in oncology, pulmonary 
medicine, and gastroenterology. 
Sidney Kimmel, Chairman and CEO of Jones New York, donated 
funds to establish the Kimmel Cancer Center, which has been 
designated a Clinical Cancer Center by the National Cancer Institute. 
Gifts have enabled Jefferson to recruit outstanding department chairs 
and faculty; provide students with financial aid; maintain existing 
departments and programs; build and renovate educational facilities; 
purchase specialized equipment; advance research by faculty and 
students; and meet other important needs. 
There is a proud tradition of philanthropy to Jefferson. In his March 
11, 1871, address to the newly formed JMC Alumni Association on 
its first anniversary, its president, Samuel D. Gross '1828, Professor 
of Surgery, counseled that "measures should be adopted to endow 
scholarships and professorships" and encouraged alumni "to aid in 
such a praiseworthy enterprise." This inspired an alumni fund-raising 
effort, initiated in 1872, that secured over $350,000 to purchase a site 
and erect Jefferson's first definitive hospital, which opened in 1877. 
In 1910, Maria Gross Horwitz, daughter of Dr. Gross, established 
Jefferson's first endowed chair, which was named for him. In 1948, 
Louis H. Clerf '12 established the Alumni Annual Giving Campaign. 
In 1971, the President's Club was established to recognize alumni 
and friends who contribute $1,000 or more to Jefferson. 
Through the years, many alumni and friends have helped Jefferson 
continue its tradition of excellence. J. Wallace Davis '42 chaired the 
Annual Giving Fund Committee of the Alumni Association for 34 
years until 1998, its 50th anniversary. With his wife, he established 
The Benjamin and Mary Siddons Measey Foundation, the W. W. Smith 
Charitable Trust and Mary L Smith Charitable Lead Trust, and the Dr. 
Ralph (JMC'07) and Marian Falk Medical Research Trust are among 
the many that have greatly benefited JMC. The Measey Foundation has 
provided numerous scholarships to students at the medical college and 
helped establish the William Maul Measey Professorship of Surgery. 
The two Smith Trusts have funded Jefferson's research in heart 
disease, AIDS, and cancer, and the W. W. Smith Trust endowed the 
William Wikoff Smith Chair in Cardiac Research. The Falk Trust has 
significantly advanced the landmark cancer research of internationally 
renowned geneticist Carlo M. Croce, M.D. 
As changes sweep through the health care environment, private 
generosity is increasingly important to Jefferson's ability to attract the 
best and brightest faculty and students, enabling it to balance its 
missions of teaching, providing the best patient care, and engaging in 
medical research. To date, there are 31 endowed professorships and 
117 endowed scholarship and loan funds, which honor distinguished 
faculty and alumni as well as other friends. 
The landmark Jefferson 2000 Fund Campaign, which includes the 
Alumni Annual Fund, has raised more than $192 million toward its 
goal of $200 million to fund initiatives that fulfill the university's 
mission. Thanks to the continuing philanthropy of alumni and friends, 
JMC approaches the future with capability and strength. 
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"Oh for a glance at the profession half a century hence when man, enlightened and refined by education, 
shall reflect more perfectly the image of his Maher!"—Samuel D. Gross '1828, Chairman of Surgery and world-renowned teacher 
Imagine Our Future 
As we prepare the next generation of health care professionals, Jefferson must be vigilant, flexible, and willing to take prudent 
chances. With creative ideas and dedicated people, the university has a 
very bright future. 
No doubt, there will be challenges. Discussing the prospects of the 
university and the health system, President Paul C. Brucker, M.D. 
foresees further cutbacks in physician and hospital reimbursements, 
particularly in areas where the rates are perceived to be overly 
generous, for example cataract surgery or cardiac surgery. Managed 
care, he says, aims to pay less for health care while doctors and 
hospitals pay more through decreased reimbursements. 
In the Philadelphia region, the turbulence will continue. The health 
care industry is a major regional economic engine, accounting for 
200,000 jobs in the five-county Philadelphia area and pouring 13 to 15 
billion dollars yearly into the economy. On the other hand, 30 to 50 
percent of local hospital capacity is no longer needed for acute care and 
must be either closed or converted to another use by the year 2002, 
leading to the closure of between 15 and 25 acute care hospitals. In 
addition, two insurers control 90 percent of the local market, making it 
more difficult for hospitals to negotiate favorable contracts. 
Dr. Brucker says the Jefferson Health System is now basically complete. 
Its members are strong institutions, appropriately located across the 
Delaware Valley. Areas needing future attention include obtaining a 
single contracting agreement with payers; regionalizing some clinical 
services; developing clinical leadership for the system; and taking 
advantage of the alliance with the duPont Hospital for Children to 
develop stronger outreach programs in pediatrics. 
One of Jefferson's goals is to rank among the top 25 medical schools in 
research, he adds. Acknowledging lack of space as the principal 
limitation to expanding laboratory activity, he foresees that some of the 
researchers and clinicians of the Kimmel Cancer Center may relocate to 
a dedicated structure of their own on campus, with expanded facilities 
and personnel. 
Preparing Medical Students 
for the 21st Century 
Jefferson's educational programs are continually evolving in 
response to 
• the importance of molecular understanding of disease; 
• a decreasing pool of inpatients for study as more patient care is 
moved to ambulatory settings; 
• changes in how faculty members practice, brought about by the 
pervasiveness of managed care; and 
• the need to teach students how to be effective doctors in a managed 
care environment. 
In 1993, the Liaison Committee on Medical Education commended the 
Jefferson curriculum for combining traditional with experimental 
elements, emphasizing basic science as a foundation for clinical 
activities. 
Jefferson is unusual among U.S. medical schools for developing an 
instrument to measure the quality of its educational efforts: the 
Longitudinal Study of Medical Education, implemented in 1970 under 
the guidance of Joseph S. Gonnella, M.D., now Dean and Senior Vice 
President for Academic Affairs. 
Since its inception, the Longitudinal Study has acted as the eyes and 
ears of Jefferson's curriculum development, systematically tracking the 
performance during and after medical school of over 7,600 medical 
students. The study seeks to determine whether Jefferson's graduates 
have the essential knowledge, judgment, and attitude to provide quality 
care to their patients, and how they compare to graduates of other 
medical schools. 
Future projects using the Longitudinal Study database include a study 
of workforce issues with two economists from the Wharton School of 
the University of Pennsylvania, looking at how people form income 
expectations. Another is a survey of graduates who have been 
practicing longer than five years, asking, "How did your Jefferson 
education help you professionally?" 
Jefferson's Physician Shortage Area Program, established in 1974, 
recruits applicants from rural communities who intend to practice 
family medicine in rural and underserved regions, especially in 
Pennsylvania. PSAP students (an average of 15 per year) have family 
physician faculty advisors, serve their required third-year family 
medicine clerkships in a rural location, take their senior outpatient 
subinternship in family medicine (usually with a rural preceptor), and 
receive financial aid in the form of loans. After graduating, they are 
expected to complete a residency in family medicine and to practice in 
a rural and underserved area. 
An article in the January 20, 1999 Journal of the American Medical 
Association, describing the impact of PSAP after 22 years of operation, 
40 	 JEFFERSON Medical College Alumni Bulletin 	 June 1999 	 175th Year 
Residents and 
faculty discuss 
anesthesiology to 
relieve the pain of 
a severely injured 
spinal cord injury 
patient. 
reported that PSAP graduates account for 21 percent of family 
physicians practicing in rural Pennsylvania who graduated from one of 
the state's seven medical schools. PSAP graduates were more likely 
than their non-PSAP Jefferson classmates to practice in a rural area, to 
practice in an underserved area, to practice family medicine, and to 
have combined a career in family medicine with rural practice. In 
addition, program retention has remained high. The program serves as 
a model for health policymakers and other medical schools. 
The flood of new information from molecular biology, biochemistry, 
and molecular pharmacology over the past 20 years will demand a new 
breed of doctor for the next century. Advances in fields such as 
oncology are already bringing molecular diagnostics and therapeutics. 
Jefferson students learn molecular medicine through correlative 
teaching which presents it in a clinical context. The goal is to prepare 
them to assimilate additional molecular knowledge as it is uncovered in 
the future. 
The rapid expansion of the scientific database has led to a blurring of 
traditional barriers between basic science departments. This blending 
of disciplines has had a positive effect on teaching by allowing 
information to be presented to students in a more sequential fashion. 
Physiology, for example, now integrates subcellular and molecular 
information with the study of organ systems. 
THE IMPORTANCE OF RESEARCH 
Jefferson today has a claim to being a particularly well balanced 
medical school, boasting not only clinical training but also productive 
basic research, clinical research, and translational research, which 
bridges the gap between the laboratory bench and the bedside. 
In 1980 only 20 percent of the Jefferson faculty were engaged in 
sponsored research; by 1997 this number had climbed to 50 percent. 
Access to laboratories, Jefferson's excellent medical library, and 
stimulating colleagues results in a continuing infusion of new ideas. 
The total funding received by Jefferson in 1997-98 from the National 
Institutes of Health as well as from nonfederal grants came to over 
$80 million. Jefferson ranked in the upper third of all 125 American 
medical schools in research funding, a remarkable advance from its 
ranking two decades earlier. According to the 1998 NIH Report of 
Extramural Awards to Medical Schools, certain Jefferson departments 
stood out: 
• Microbiology and Immunology, and Dermatology and Cutaneous 
Biology, both ranked first among all schools receiving grant funds. 
• Pathology/Anatomy/Cell Biology, and Orthopaedic Surgery, both 
ranked sixth among all schools in funding. 
AN INSTITUTIONAL BENEFIT FROM RESEARCH 
The Bayh-Dole Act, passed by Congress in 1980, allows universities to 
retain and commercialize the rights to scientific discoveries and 
inventions arising from federally funded research. This has resulted in 
a faster transfer of scientific advances from laboratory to bedside and, 
as a fortunate byproduct, has meant significant additional funding 
for universities in the form of licensing fees, royalties, and equity 
holdings. To fully realize these benefits, Jefferson formulated its first 
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Dr. Brucker and Mr. Farber 
system with honor, character, and integrity; and Whereas, under Dr. 
Brucker's guidance the Jefferson name has gained local, national, and 
international recognition for high levels of excellence and distinction: 
"Therefore, be it known that the Trustees of Thomas Jefferson 
University hereby formally and officially express their appreciation 
and gratitude to Paul C. Brucker, M.D., for his steadfast leadership of 
both Thomas Jefferson University and the Jefferson Health System 
during this critical time." 
On October 31, 1998, Dean Gonnella received the Abraham Flexner 
Award from the Association of American Medical Colleges for his 
distinguished service to medical education over the past 30 years. 
The citation noted that Dr. Gonnella, as dean since 1984, moved 
Jefferson from the lower third to the upper third of schools in terms 
LL of NIH support and helped garner national recognition for a well 
o balanced program. 	
Dr. Gonnella 
Dr. Gonnella's strong 	 '2 
interest in primary care 
helped establish the Department of 
Family Medicine and the nation's 
first required clerkship in family 
medicine. The citation also noted 
that Dr. Gonnella in 1968 created 
the Jefferson Center for Research in 
Medical Education and Health Care, 
one of only three centers of 
excellence for research in medical 
education recognized by the U.S. 
Department of Health and Human 
Services. The center maintains 
Jefferson's unique Longitudinal 
Study of Medical Education begun 
by Dr. Gonnella in 1970. 
The thoughtful and effective leadership of Jefferson's administration by 
President Paul C. Brucker, M.D. and Dean and Senior Vice President for 
Academic Affairs Joseph S. Gonnella, M.D. was publicly acknowledged in a 
surprise ceremony conducted by Jack Farber, Chairman of the Board of 
Trustees, at the September 1998 board meeting. Commending President 
Brucker's stewardship in these turbulent times for health care, the trustees 
presented him with the following resolution: 
"Whereas, Paul C. Brucker, M.D., has served with distinction as President of 
Thomas Jefferson University since 1990; and Whereas, Dr. Brucker was elected 
to serve as the first Chairman of the Board of the Jefferson Health System upon 
its formation and has performed in this capacity with distinguished profes-
sional commitment; and Whereas, through his leadership and vision he has 
strengthened both Thomas Jefferson University and the Jefferson Health System 
during a tumultuous time for academic health centers; and Whereas, he has 
given total dedication and effort to serving both the university and the health 
patent policy in 1982 and established its Office of Technology Transfer 
in 1984. 
U.S. patents granted to Jefferson investigators during fiscal 1998 
totaled 34, the majority being in the Departments of Microbiology and 
Immunology, Medicine, Anesthesiology, Biochemistry and Molecular 
Pharmacology, and Pathology, Anatomy, and Cell Biology. Over the 
past three years, 15 new companies have been established based on 
Jefferson research. These are companies in which Jefferson has or will 
receive equity. In the past two annual surveys of technology transfer 
activities at U.S. universities, Jefferson ranked in the top 10 in the 
number of start-up companies created and in the top 15 in new 
research funding from technology licensing agreements. 
Nine of the 15 new companies have promised substantial new research 
funding to Jefferson. Five will provide at least $1 million each; one 
will provide $3 million over three to four years. During fiscal 1998, 
Jefferson received $6 million from licensing fees, royalties, and equity 
holdings from technology transfer activities. 
Renato Baserga, M.D., Professor of Microbiology and Immunology 
and Deputy Director of the Kimmel Cancer Center, now holds six 
patents on his discoveries, three of which have been picked up by 
pharmaceutical companies who pay licensing fees and royalties to 
Jefferson. Such royalties create a more secure source of funding than 
continued student tuition increases. Nevertheless, technology transfer 
is a serendipitous outcome of basic science findings, not the engine 
driving the research. The purpose of Jefferson research is to uncover 
new information, to teach it to our students, and to use it to help our 
patients. If Jefferson can do this and still capture extra funds, so much 
the better. 
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Education 
Recent innovations in graduate education at Jefferson promise to 
improve patient care. A live telecast of a cardiac procedure from 
Philadelphia to Baltimore, Maryland this past year was the first to be 
performed at Jefferson and transmitted live to a remote site. Arnold J. 
Greenspon, M.D., Director of the Cardiac Electrophysiology 
Laboratory, led the procedure, and Jefferson staff produced the live 
telecast sent to 1,000 electrical engineers gathered at the Baltimore 
Convention Center. This technology is now being developed for wider 
use in Jefferson's graduate programs, both on site and at a distance. 
A second effort, the Jefferson Health Care College, was developed in 
response to the changing pressures on primary care physicians in the 
Jefferson Health System and across the Delaware Valley. The faculty for 
this effort includes both primary care physicians and Jefferson 
specialists. Its goal is to leverage Jefferson's strong teaching and 
research to assist practicing physicians to provide the best possible 
patient care. Directors are Gino J. Merli '75, Clinical Professor of 
Medicine, and Richard C. Wender FP'82, Clinical Professor of Family 
Medicine, along with Timothy Brigham, Ph.D., Assistant Dean for 
Graduate and Continuing Medical Education. 
The Health Care College's mission is: 
• targeting the practicing physician, using a cohesive curriculum of 
timely topics to improve clinical practice; 
• incorporating the principles of managed care into the daily practice of 
the physician; 
• fostering multidisciplinary patient care approaches involving both 
primary care practitioners and specialists; and 
• improving the health of the patients being seen by these physicians. 
Courses include evidence-based care, disease management, and clinical 
practice management. 
As science moves into the 21st century, investigations into the molecular 
pathogenesis of diseases will be spearheaded by collaborations between 
medical biologists and other fields, such as physical scientists and 
engineers. One area in which partnerships are being fostered is the new 
Ph.D. program in Cell and Tissue Engineering directed by Rocky S. 
Tuan, Ph.D., Professor of Orthopaedic Surgery. Previously, the 
development of less expensive technologies in this area—and the 
education of graduate students—had been undertaken by several 
departments. To achieve more unity of purpose, the Cell and Tissue 
Engineering program unites various research faculty, as well as 
scientists from Drexel University's School of Biomedical Engineering, 
in a multidisciplinary approach. 
Basic Research 
Jefferson is now in the vanguard of molecular and genetic investiga-
tions. The nationwide explosion in research since 1953 was touched off 
by the description by Watson and Crick of the double helical structure 
of DNA, which contains the genetic information passed from parent to 
offspring. Genes, the units of DNA that encode physical attributes and 
dictate the normal functioning of body processes, code for proteins, the 
metabolic regulators of the body. 
Because all DNA is composed of four bases that can be placed in any 
order, it is possible to change their number, order, or both to make 
Poster presentations at Student Research Day (time-lapse photo) 
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new types of organisms. Recombinant DNA technology—popularly 
known as gene splicing—is improving quickly enough that genetic 
engineering may be a dominant science of the 21st century. 
Other avenues of genetic research being pursued at Jefferson are 
processes of cell life and cell death. Normal cell death is controlled by 
apoptosis, a genetically programmed process that can become deranged 
when the components of the apoptotic machinery are mutated or are 
present in inappropriate quantities. Such derangement can contribute 
to cancer, neurodegeneration, autoimmunity, and heart disease. 
Normally, the tips of chromosomes, called telomeres, shorten each 
time the cells replicate. Generally the process stops after about 50 
replications, known as the Hayflick limit. Telomerase, the enzyme that 
causes the telomeres to lengthen, can extend the telomeres and 
lengthen the life span of cells in culture by at least 20 replications past 
the Hayflick limit. Recent research has shown that inserting a gene for 
the protein component of telomerase into aging human cells reextends 
their telomeres to lengths typically seen in young, healthy cells, and 
that these cells display all the characteristics of young, healthy ones. 
These results have significance for the fundamental cellular 
mechanisms underlying human aging, and may clarify our 
understanding of cancer, atherosclerosis, osteoarthritis, macular 
degeneration, and Alzheimer's. 
To survive, all cells require the mechanisms of growth factors, which 
give them signals to grow, to differentiate, or to die. Different growth 
factors exist for different cell types; however, all cells except liver and 
blood share one growth factor—insulin growth factor—which has been 
A gene can be influenced by surrounding genes, by the cell's 
environment, and by the larger ambient in which the organism 
exists. Harmful influences, such as environmental carcinogens, 
can cause mutations and translocations resulting in disease. 
A major field of research at Jefferson involves how gene translo-
cations—transposition of genes to another site—lead to cancer. 
Carlo M. Croce, M.D., Chairman of Microbiology and 
Immunology and Director of the Kimmel Cancer Center, has 
made numerous discoveries about oncogenes. It was he who 
found that the translocation of the bcl-2 gene from chromosome 
14 to chromosome 18 is a critical event in the development of 
lymphoma. Similar translocations cause acute promyelocytic 
leukemia and chronic myelocytic leukemia. 
We also know that certain genes can repair DNA damage. But if 
these genes mutate, DNA errors are amplified, leading to cancer, 
particularly when certain chemicals have been present in the 
environment. 
   
Dr. Baserga 
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proven to induce apoptosis. 
Genetic mutations can influence 
the action of cellular growth 
factors—another area demanding 
our attention. 
CANCER RESEARCH Dr. Croce 
In cancer, genes and chromosomes become disorganized, leading them 
to enact genetic programs far different from those intended. The goals 
of Jefferson investigators are to understand the specifics underlying the 
transformation of a normal cell into a malignant one, and to use gene 
therapy to inactivate the malignant cell. 
Jefferson's current extramural cancer research support approximates 
$50 million per year. The university is among the nation's leaders in 
leukemia and colon cancer research, as evidenced by the recent identi-
fication of the TCL-1 gene, one of a group of genes believed to be 
implicated in the proliferation of T-cells and B-cells. Cancer occurs 
when TCL-1 is translocated from its normal sequence on chromosome 
14 and is placed next to genetic elements known as enhancers which 
cause the gene to produce too much protein. TCL-1 is the first gene to 
be implicated in low-grade leukemias such as T-cell prolymphocytic 
Dr. Huang 
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leukemia, T-cell chronic lymphocytic leukemia, and adult T-cell 
leukemia. 
Other discoveries by Dr. Croce's team include the involvement of 
immunoglobulin loci and the C-myc oncogene in Burkitt's lymphoma, 
identification of the bcl-2 gene involved in follicular lymphoma, identi-
fication of the ALL-1 gene which causes acute leukemia, and 
understanding why the Pla2s enzyme protects against colon cancer. 
As researchers work out the details of how the ALL-1 gene works, 
Jefferson's Rational Drug Design Program can help develop effective 
treatment for leukemia. Rational drug design uses computer databases 
of molecular structures, and high-end graphical software to create new 
molecules and proteins. Also known as structure-based design, it holds 
great promise for translating basic science discoveries into new 
medicines. 
It begins with the structural identification of a molecular target—
such as a protein—by genetic and molecular biological techniques, 
high-resolution crystallography, and nuclear magnetic resonance 
spectroscopy. Next, the software aids in generating designs for potential 
drug molecules capable of regulating the function of the target. The 
designed molecules are then synthesized, modified, and tested for 
biological efficacy through in vitro 
and in vivo assay systems. Finally, 
the most promising candidate is 
generated for clinical trials. 
For example, white blood cells 
called CD4 cells are part of the 
body's machinery to amplify the 
immune system. In 1995, an 
analog peptide which mimicked a 
CD4 surface involved in 
stimulating the immune system 
was designed by Assistant 
Professor Ziwei Huang, Ph.D. 
Preclinical efficiency and toxicity 
studies of this analog CD4 
showed positive results in both 
mice and humans in the treatment 
of multiple sclerosis and 
transplantation rejection. Clinical 
trials are being undertaken. 
Dr. Huebner 
Dr. Croce and Professor Kay Huebner, Ph.D. recently discovered the 
FHIT gene, the second largest gene yet identified, which is involved in 
the development of small cell lung cancer, cervical cancer, and gastric 
cancer. The product of FHIT is the tumor-suppressing Fhit protein. 
FHIT mutates predominantly by deletion; 75 percent of small cell lung 
cancers show FHIT deletions. These mutations occur early in tumor 
development, and smoking has been shown to initiate FHIT mutation. 
The gene has also been shown to mutate in 80 percent of cervical 
cancers. 
Although much work remains before the mechanisms of FHIT action 
are totally comprehended, the National Cancer Institute has called the 
discovery "the Rosetta Stone of cancer research." Once its mechanisms 
are clarified, gene therapy trials will be designed. 
Other scientists at the Kimmel Cancer Center recently identified 
PISSLRE, a protein essential to normal cell growth and division. It 
apparently becomes activated during the G-2 phase of the cellular life 
cycle and continues to exert its effect until the M phase. Expression of 
PISSLRE is essential for human cells to grow and divide properly, and 
for mammalian cells to move from the G-2 to the M stage. 
Scientists led by Antonio Giordano, M.D., Ph.D., Associate Professor of 
Pathology, Anatomy, and Cell Biology, are studying the relationship 
between proteins and the cellular life cycle. Since regulatory proteins 
are present only in dividing cells and are activated only at specific times 
within the cell cycle, it should be possible to develop drugs that target 
only proliferating cells, with no side effects to resting cells. In addition, 
various cell cycle regulatory proteins are present in tumor cells but not 
in normal cells, making the targeting of tumor cells a distinct 
possibility. 
Dr. Giordano was the first to discover a direct physical link between 
cell cycle regulation and cancer. He demonstrated that in order for 
human cells to transform and become cancerous, oncogenes must 
interact directly with cyclin and CDK molecules, thus effectively 
deregulating the cell cycle. Normally, in humans, if the body senses 
alterations in the cell growth or division process, cells are induced by 
their DNA either to stop dividing, or, if they have suffered damage, to 
undergo apoptosis. When errors in the chromosomes are present, the 
genes may produce abnormal cyclins and CDKs that permit a 
molecular cascade culminating in cancer. 
Dr. Giordano also led a team including collaborators from the Second 
University of Naples, Italy, who found evidence that damage to Rb-
2/p130, the human retinoblastoma-related gene, may lead to lung 
cancer. This suggests that cigarette smoking, air pollution, toxins 
breathed by workers, and other environmental carcinogens may cause 
the damage and inhibit the body's ability to make the Rb-2/p130 
protein, a powerful tumor suppressor. The team is creating an early 
detection and tumor grading test for lung cancer, to enable physicians 
to assess the amount of Rb-2/p130 protein present in individual 
patients. Since Rb-2/p130 levels correspond to the stage of lung cancer, 
this test could be of immediate benefit in determining the aggres-
siveness of individual tumors. Clinicians may be able to begin 
treatment earlier and tailor it to how aggressive the tumor is. 
Eventually, they may be able to develop gene therapy. 
v.." 
NITRO IE CANCF Dr. Giordano 
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transduction factor. Therapeutics will be oriented toward a process 
instead of toward the disease, for example targeting apoptosis, a 
process which is important in normal immunology as well as in cancer. 
Antisense therapy combined with immune system stimulation also 
offers hope for the treatment of cancer. Antisense DNA drugs work by 
binding to RNA messages from disease genes. RNA messages carry the 
genetic code for a specific protein, a process called "sense orientation." 
The complementary strand in a double helix is called antisense. The 
antisense DNA drug attaches to the sense RNA message like a matching 
puzzle piece. Once bound, the drug prevents the gene from being 
copied or the message from being read, and thus bars tumor formation. 
A group led by Renato V. lozzo, M.D., Professor of Pathology, 
Anatomy, and Cell Biology, recently demonstrated that decorin, a 
natural substance normally present in the outer hull of human cells, 
may be a key to stopping the growth of tumors. Decorin appears to 
suppress tumor cell growth by converging with epidermal growth 
factor to affect the cancer cell's life cycle. In its natural role in 
connective tissue, decorin helps regulate cell growth by interacting 
with growth factors and collagen. The team has selectively engineered, 
or transfected, colon cancer cells with decorin DNA; cell growth was 
either slowed or did not occur. 
Some forms of colon cancer develop when mismatch repair genes go 
awry. These genes are part of the molecular machinery that fixes the 
cell when DNA replication does not work correctly; for normal 
development, precise nucleotide pairing is required. Richard Fishel, 
Ph.D., Professor of Microbiology and Immunology, and colleagues 
have uncovered a two-gene molecular switch by which mismatch repair 
is triggered. Frequently, only two genes, MSH2 and MLH1, are altered 
in hereditary nonpolyposis colorectal cancer, which accounts for 10 to 
15 percent of all colorectal cancers. The molecular switch is turned off 
when a molecule of adenine triphosphate is attached to the complex. 
When a phosphate molecule is removed, leaving adenine diphosphate, 
the switch is turned on and binds with the mismatch. 
FUTURE CHALLENGES 
A major challenge for the future, Jefferson cancer researchers agree, 
will be to develop more specific blood tests, or cancer markers, so that 
we know when a malignant process has occurred in a specific organ. 
Within the next quarter century, treatment may be based on molecular 
definition of therapeutic targets. In other words, to fight breast cancer, 
clinicians will focus on a specific tumor suppressive gene or signal 
FURTHER AVENUES OF BASIC INVESTIGATION 
A gene repair technology may hold promise as a treatment for sickle 
cell anemia and allied diseases by correcting the DNA mutation from 
which they arise. The new technology, developed by a team led by 
Eric Kmiec, Ph.D., Associate Professor of Biochemistry and Molecular 
Pharmacology, uses therapeutic gene sequences called chimeraplasts to 
correct the specific point mutation. 
Chimeraplasty may provide an effective treatment for an array of 
diseases with a genetic basis similar to sickle cell anemia. It also may 
have repercussions for two categories of gene therapy. The first, gene 
Dr. Fishel 
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augmentation, incorporates a correct copy of a gene into a diseased 
cell, which then expresses the normal protein. The second category, 
which includes chimeraplasty, is known as chromosomal targeting, or 
gene correction. This technique aims to correct or eliminate a given 
gene from within the chromosome. 
Rocky S. Tuan, Ph.D., Director of Orthopaedic Research, supervises a 
program examining the fundamental mechanisms in the formation of 
cartilage and bone. Embryonic skeletogenesis involves the sequential 
events of patterning, cell differentiation and maturation, and morpho-
genesis. The major functional role of the skeleton in humans requires 
that skeletogenesis and chondrogenesis be under stringent regulation at 
multiple levels. 
Transcription factors, extracellular matrix molecules, growth factors, 
membrane receptors, and cell adhesion molecules all play important 
regulatory roles in cartilage development. Control of cartilage 
maturation and regulation of the 
hypertrophy program of the 
chondrocytes (which is crucial for 
the transition from cartilage to 
bone) involves apoptosis, cell 
volume changes, shifts in cellular 
energy metabolism, and matrix 
mineralization. Perturbations in 
any of these steps can produce 
growth abnormalities. 
Osteogenesis versus chondroge-
nesis, Jefferson investigators have 
demonstrated, is a differentiation 
process dependent on cell origin, cell-cell interactions, cell-matrix 
interactions, and signalling by growth and differentiation factors, as well 
as by systemic influences—all in the context of morphogenetic control by 
patterning genes. 
GENE THERAPY 
Strategies to treat defective genes can involve 
• introducing a cell-killing drug activated when a viral protein is turned 
on after a virus invades a cell, and 
• increasing the visibility of abnormal cells so that the patient's immune 
system targets them for destruction as foreign cells. 
Gerald Litwack, Ph.D., Chairman of Biochemistry and Molecular 
Pharmacology and Associate Dean for Scientific Affairs, cautions that we 
should not become too optimistic too soon about effective gene therapy 
for most human diseases. It is a decade or two away, because the vector 
systems needed to convey genes into human tissues are not fully worked 
out. But already Jefferson scientists are refining vector systems, and are 
uncovering more and more genetic targets that eventually will be 
corrected by gene therapy. 
Genetic manipulation to prevent disease is farther in the distance. Dr. 
Litwack notes that methods that work in animals often do not work in 
humans because of differing self-protective mechanisms. Nevertheless, 
we are learning which molecules we'll have to change in order to prevent 
a particular disease process from starting. 
Translational and Clinical 
Research 
Translational research carries the findings of basic science from the 
laboratory bench to the patient's bedside, leading to clinical research 
designs and clinical trials, including gene therapy. Phase One clinical 
trials, overseen by Robert L. Capizzi, M.D., Magee Professor and 
Chairman of Medicine, are carried out at the Clinical Research Unit on 
the 11th floor of Thompson Annex. Phase Two trials are conducted 
under the direction of the specific subspecialties involved. Phase Three 
trials can be expedited through the clinical facilities in the Jefferson 
Health System, providing a large pool of potential candidates. Phase Four 
trials—meaning post-marketing surveillance—can be carried out in 
Jefferson's extensive primary care network. The development of the 
health system and the establishment of primary care and specialty 
networks ease the participation of community physicians in clinical trials. 
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The Kimmel Cancer Center is presently supervising six clinical trials in 
the Jefferson Cancer Network, and that number is expected to double 
within a year. WalterJ. Curran, Jr., M.D., Chairman of Radiation 
Oncology, is the center's clinical director. 
Jack London, Ph.D., Director of the Laboratory for Applied Computing 
at Kimmel, was nominated for a Computerworld Smithsonian Award 
for "Facilitating Access to Optimal Cancer Center." This low cost video 
conferencing project uses personal computers to facilitate consultations 
between community physicians and Jefferson cancer specialists. 
London notes that the public sometimes has a negative view of clinical 
trials, likening them to human experimentation. People want to receive 
the best treatment available, but do not understand that cancer clinical 
trials provide the most current therapy. The Internet can dramatically 
increase the spread of information about currently available trials to 
patients and to community physicians. 
CLINICAL CANCER RESEARCH 
Specific blood tests can provide either direct or indirect markers of a 
specific type of cancer. Prostate specific antigen (PSA), for example, is a 
direct marker for prostate cancer; a rising PSA serum level is strongly 
indicative of prostate cancer. Carcinoembryonic antigen is an indirect 
marker: it can be 
moderately elevated in 
noncancerous diseases 
such as hepatitis or 
bronchitis, especially the 
chronic form of 
bronchitis associated 
with smoking, but is 
markedly elevated in 
colorectal, pancreatic, 
breast, bladder, and 
many other cancers. 
Scott A. Waldman, M.D., 
Ph.D.'80, Director of 
Clinical Pharmacology 
and the Clinical 
Research Unit, led a 
team which discovered a 
possible additional 
marker for colon cancer. 
The protein guanylyl 
The Clinical Research Unit, directed by Dr. Waldman, 
includes patients in all age ranges. 
cyclase C (GCC) is expressed in humans solely by two cell types, the 
single layer that lines normal intestines, including the colon and 
rectum, and the malignant form of these cells following their transfor-
mation and metastasis outside the intestines. GCC's specificity may 
allow its use as a marker for colorectal tumors that metastasize outside 
the intestines. 
An international team from Jefferson's Department of Pathology, 
Anatomy, and Cell Biology and two Italian universities have made an 
important observation about the tumor suppressor gene Rb-2/p130. 
The lower its level in endometrial cancer cells, the more aggressive the 
disease will be, and the greater the likelihood that the patient will die. 
These findings imply that Rb-2 is a strong factor in protecting normal 
cells from turning malignant. 
The investigators suspected an Rb-2-endometrial cancer link when they 
noticed similar mechanisms in lung cancer. They examined 100 
patients who had undergone surgery for endometrial cancer and had 
received no prior radiation treatment or chemotherapy. Five years 
postoperative, lower levels of Rb-2/p130 corresponded to a higher than 
normal risk of endometrial cancer recurrence and fatality. Eventually, 
this finding could lead to tests predictive of disease severity and 
recurrence, allowing doctors to select which patients require less 
aggressive surgery. 
a 
RADIATION THERAPY 
- 5 
The Bodine Center for Cancer Treatment is testing an innovative 
radiation treatment for brain tumors, Intensity Modulated Radiation 
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Therapy, along with its delivery system, termed Peacock. This new 
technology promises more precise treatment for hard-to-reach cancers, 
especially in the head, neck, and spine. Its efficacy lies in its ability to 
focus high-dose computerized radiation only on the tumor, even if its 
shape is irregular, thus sparing normal, healthy tissue. Patients first 
undergo computed tomography imaging to define precisely both the 
tumor and adjacent normal tissues. A computer subsequently marks as 
many radiation targets in the tumor as necessary. 
Bodine Director Curran notes that although this technology requires 
major expertise in medical physics, it is conceptually revolutionary and 
holds great potential. Jefferson is the first medical center in the 
Delaware Valley, and one of approximately 26 nationwide, to provide 
it. The Department of Radiation Oncology will participate in 
multicenter clinical trials to establish long-term data on the 
effectiveness of Peacock as compared to conventional radiation 
therapy. 
The department is involved in several other cancer clinical trials. LAMP 
is a 40-center, randomized trial investigating stage three non-small cell 
lung cancers. Enrolled patients receive both chemotherapy and 
radiation to see whether the order of treatment affects clinical 
outcomes. Dr. Curran notes that Paclitaxel, a chemotherapy drug, 
shows promise in treatment of ovarian and breast cancer. The lives of 
patients with stage three non-small cell lung cancer can likely be 
improved by combining such drugs with state-of-the-art radiotherapy. 
Professor Dennis B. Leeper, Ph.D. received renewal of the grant 
"Modification of Hyperthermia Response," studying how tumor cells 
adapt to growth in an acidic environment, and the mechanism by 
which acidification sensitizes human melanoma cells to pH-dependent 
therapeutic agents. The program, now in its fifth year, will receive 
almost $4 million over the next three and one-half years. Over 25 
researchers from seven Jefferson departments and other institutions are 
involved. Goals include laboratory studies of tumor acidity compared 
with normal tissue, and evaluation of the potential for improving 
cancer treatment while sparing normal tissue. 
GENETIC TESTING 
Bruce M. Boman, M.D., Ph.D. brings particular expertise in hereditary 
nonpolyposis colon cancer and familial adenomatous polyposis to his 
new position as Director of Medical Oncology and Medical Genetics. 
His division offers family pedigree analysis and genetic testing for 
hereditary syndromes. They collaborate with Jefferson's Familial 
Colorectal Cancer Registry. 
Computer software helps them uncover associations between genes and 
diseases, especially through statistical analysis of family data. To sort 
out the confounding influence of the environment in the development 
of cancer, researchers use linkage analysis, which pairs the trait under 
investigation with previously identified gene loci, or markers. When 
the trait and a marker are consistently inherited together, they are said 
to be linked. If a candidate gene associates with the trait under 
investigation, it is likely that a contributory gene has been discovered. 
The next step is to fully prove the association between gene and 
inherited trait. 
NEUROSURGERY 
In 1996, the Department of Neurosurgery teamed with specialists at 
Wills Eye Hospital to form the Neurosensory Institute. Its divisions 
include interventional neuroradiology and radiosurgery, staffed by 
surgeons, radiation oncologists, neuro-oncologists, and 
neuroradiologists. 
The Neurosensory Institute provides leading-edge technology for the 
noninvasive and minimally invasive treatment of neurological and 
vascular disorders such as brain tumors, aneurysms, and arterial 
malformations. Clinical Professor H. Warren Goldman, M.D., Ph.D. 
directs the gamma knife unit at Wills, the only one in the Delaware 
Valley. The gamma knife is a noninvasive, extremely precise surgical 
device for treating deep-seated or critically located brain tumors, brain 
vascular abnormalities, Parkinson's disease, and other movement 
disorders. Over 200 beams of ionizing energy are focused on the 
abnormality in a dose strong enough to inactivate the growth. There is 
minimal exposure to healthy surrounding tissue, which makes this a 
feasible option for tumors considered too deep for more conventional 
surgical approaches. 
The Varian GOOSR is an oncology unit dedicated to head-only stereo-
tactic radiation. This linear accelerator—one of only two in the 
U.S.—delivers focused radiation in either a single dose or in multiple 
fractions, making the unit exceptionally versatile for treating certain 
brain tumors and other brain disorders. 
David W. Andrews, M.D., Director of the Division of Neuro-oncologic 
Neurosurgery, Dr. Renato Baserga, and fellow researchers have 
identified the BRAG-1 gene that appears to contribute to the 
development of gliomas. BRAG-1 (brain related apoptosis gene) is a 
central nervous system gene and a member of the Bcl-2 family whose 
members block apoptosis when aberrantly expressed. It is found in all 
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brain cells, but a defective copy appears 
in cells from gliomas. Gliomas are 
believed to occur because BRAG-1 has 
been mutated or translocated, abnormally 
prolonging the lifespan of the host cell 
and setting the stage for cancerous 
mutations. When BRAG-1 functions 
normally, the glial cells follow a natural 
cellular program for cell death. 
All living cells require growth factors, 
which act through cell receptors, or 
docking proteins. Once the growth factor 
reacts with the cell receptor, a signal is sent out telling the cell to grow, 
to differentiate, or to die. Dr. Baserga's laboratory has shown that the 
cell receptor for IGF-1, present in all cells except liver and blood cells, 
is crucial to all three cellular responses, and that when the IGF-1 
receptor is impaired, tumor cells die, but normal cells do not. His team 
experimentally impaired the IGF-1 cell receptor by using a decoy 
receptor, called a dominant negative receptor, and found that no 
interaction occurs with this decoy receptor and that the tumor cells die. 
They have joined with 40 centers worldwide in the first organized 
international gene therapy trial for treatment of glioblastoma, a highly 
malignant and radioresistant brain tumor. The trial is designed to test 
whether gene therapy can delay disease progression. The treatment 
involves inserting a gene into glioblastoma tumor cells, using a herpes 
simplex virus as a vector. During brain surgery, the gene for the 
enzyme thymidine kinase is introduced into the DNA of actively 
dividing tumor cells. Patients are then given the antiviral agent 
gancyclovir. This combination destroys cancer cells in the laboratory. 
Early results from the gene therapy trial are promising, though much 
work remains to be done. 
Matthew During, M.D., Professor of Neurosurgery and Director of 
Jefferson's Central Nervous System Gene Therapy Center, has led novel 
studies in a spectrum of fields. He recently published the successful 
administering of gene therapy orally to cure lactose intolerance in rats. 
Lactose intolerance, an inability to metabolize lactose which affects 
about half the world's population, results from reduced activity of the 
enzyme lactase. Dr. During and his colleagues put a corrected gene into 
a virus and then into a liquid solution which was fed to rats. The group 
engineered a harmless version of an adeno-associated virus to which 
virtually everyone had been exposed. The gene began working in about 
20 percent of the rats' proximal intestinal anal cells, just enough to 
correct the experimentally induced lactose intolerance. Proof that gene 
therapy can work orally may lead to improved treatments for diseases 
such as diabetes. 
Andrew Freese, M.D., Ph.D., Director of Neurosurgery Research, along 
with colleagues Dr. During, Paola Leone, Ph.D., and Giancarlo Barolat, 
M.D., as well as researchers at Yale, are investigating the use of gene 
therapy to treat Canavan's disease, a rare, fatal metabolic brain disorder 
which primarily affects children of Eastern European or Ashkenazi 
Jewish background. Dr. Freese supervises a research program including 
the development of gene therapy for Parkinson's disease, epilepsy, 
cerebrovascular disorders, and pituitary tumors. He has studied the 
biochemistry of Huntington's and Alzheimer's diseases and has 
developed new drug delivery systems for neurological disorders. 
Canavan's disease is an inherited neurological disorder characterized by 
spongy deterioration of the brain. It is one of a group of genetic 
disorders called leukodystrophies that affect the growth of the myelin 
sheath of the nerve fibers in the brain. The disease results from a genetic 
flaw in which a needed enzyme 
fails to be produced, resulting in 
the overproduction of the toxic 
compound N-acetyl aspartate in 
the brain. Death usually occurs 
between the ages of five and 
seven. Canavan's disease is similar 
to Tay-Sachs disease in that both 
are metabolic disorders causing 
the buildup of toxic compounds 
that affect normal brain 
development. 
Dr. During 
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The researchers developed a gene delivery system based on liposomes 
and polymers, rather than on viruses. The system works in the 
laboratory and in animals. Preliminary studies in New Zealand have 
successfully delivered it into the brains of two children, based on 
evidence of nerve myelination and on behavioral studies. The Jefferson 
researchers have gained FDA approval to expand the work into a larger 
Phase One clinical trial. Dr. Freese hopes to extend their gene therapy 
approach to other inherited metabolic disorders, such as Krabbe's 
disease. The clinical trials may yield information applicable to treating 
neurological disorders including Parkinson's disease, stroke, and 
epilepsy. 
AIDS AND RETROVIRUSES 
Roger J. Pomerantz, M.D. heads the Center for Human Retrovirology, 
an interdepartmental effort to alleviate the suffering caused by AIDS 
and hepatitis C. The hepatitis C virus is the leading cause of chronic 
liver disease and the most frequent indication for liver transplantation. 
Since a virus lacks a nucleus but contains either DNA or RNA, it is a 
parasite that must lodge within a cell to continue to exist. A retrovirus 
carries its information as RNA, then converts to DNA, at which stage it 
is called an integrated provirus. It then makes new RNA which codes 
for protein which, in turn, makes new viruses. Hepatitis C, however, is 
an RNA virus, not a retrovirus. Its sequence of operation is genomic 
RNA to messenger RNA to protein. 
Dr. Pomerantz explains that control of retroviruses is now possible; the 
major problem researchers face is dealing with what remains of the 
post-treatment retrovirus: the integrated provirus—the integrated 
DNA—which remains intact. 
A team led by Dr. Pomerantz recently reported in the New England 
Journal of Medicine that they found HIV in potentially infectious form in 
the semen of infected men even when the virus could not be detected in 
their blood. The study's findings also suggest that HIV may not be 
eradicated by drugs alone, even with the highly active antiviral therapy. 
Using polymerase chain reaction, he and his coworkers found HIV 
integrated provirus in the semen of four of seven men. As yet there is 
no known way to eradicate the HIV integrated provirus. The team's 
results support federal recommendations regarding safe sex practices. 
Dr. Pomerantz, Hui Zhang, M.D., Ph.D., and colleagues have added two 
other important discoveries about HIV: 
• Individual, biochemically active HIV-1 viruses have permeable pores 
that make their envelope vulnerable to a group of compounds called 
nucleoside analog triphosphates which have the ability to penetrate the 
viral envelope, incorporate into the virus, and directly kill it. 
Nucleoside analog triphosphates might also act directly as virucidal 
agents in preventing transmission of HIV-I. 
• Along with Drs. Lingxun Duan and Pnina Levy-Mintz, Dr. Pomerantz 
has shown that intracellular immunized cells have the potential to 
inhibit the progression of the HIV-1 life cycle during the period known 
as integrase, or viral replication—the most difficult stage of HIV-1 to 
target for treatment. Targeting integrase molecules, which carry HIV-1 
DNA into the host cell DNA, could ultimately prevent the HIV-1 virus 
from spreading to new cells in patients already infected. 
Dr. Pomerantz is waiting for FDA approval of a proposal, already 
approved by the Recombinant DNA Advisory Committee of NIH, for 
clinical trials based on the integrase findings. The trial involves intracel-
lular immunization, the immunization of individual cells against HIV-1 
by introducing a genetically constructed antibody fragment that has 
been shown in laboratory studies to inhibit HIV-1 virus replication. 
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Three promising avenues of investigation are being pursued by 
Pomerantz's team: 
• defining the in vitro molecular pathogenesis of viral disease, in 
particular the urgent need to discover a way to inactivate the integrated 
provirus; 
• developing novel molecular- or immune-based therapies for AIDS and 
hepatitis C; and 
• creating vaccines for HIV and hepatitis C. 
VACCINES 
Although vaccines for AIDS and hepatitis C will be some time in 
coming, Jefferson investigators have already developed promising 
vaccines for other diseases. Professor of Medicine David A. Berd '68 has 
produced a vaccine that in early tests has proven effective against 
malignant melanoma. Interim results from a clinical trial showed signif-
icant improvement in four-year survival rates compared with currently 
available treatment. 
In the trial, patients with stage three tumors of the lymph nodes were 
treated with the vaccine after standard lymphadenectomy. The 
melanoma vaccine is made from a patient's tumor cells, which are 
inactivated and modified with the chemical dinitrophenyl. This process 
makes the tumor cells appear foreign to the patient's immune system 
which attacks and kills them. The vaccine is used postsurgically for 
treating advanced but surgically resectable malignant melanomas. 
Later studies have shown that the DNP vaccine causes an inflammation 
in the tumors which allows invasion by clones of T-cells which kill the 
tumor cells. Although the field of cancer vaccines is still a long way 
from consistent successes, the melanoma vaccine results are quite good. 
Using Dr. Berd's vaccine technology, he and CharlesJ. Dunton, M.D., 
Associate Professor of Obstetrics and Gynecology, have developed a 
vaccine for women with ovarian cancer. Based on initial testing on 11 
patients, the vaccine appears to be effective in stimulating the patient's 
own immune system. The vaccine is autologous, that is, prepared from 
the patient's own cancer cells. Thus, each vaccine is custom made for 
each patient. Before being reinjected, the cells are inactivated and 
treated with dinitrophenyl which, again, chemically modifies the cells 
to make them appear foreign. The next step is a randomized clinical 
trial with more ovarian cancer patients to compare standard surgery 
and chemotherapy against standard treatment plus the new vaccine. 
Professor of Medicine J. Bruce Smith, M.D. has developed a cell-based 
immunotherapy vaccine for patients with rheumatoid arthritis. The 
idea for this vaccine arose from the known phenomenon that approxi-
mately 70 percent of females with rheumatoid arthritis undergo 
symptom remission during pregnancy. It is speculated that the disease 
may become less severe during pregnancy because the mother's 
immune system manufactures proteins called cytokines, some of which 
shield the developing fetus from immune system attack and subsequent 
rejection. The cytokines also may provide a spinoff benefit by 
preventing immune system attacks on the mother's joints. 
The immune response against fetal proteins during pregnancy is 
primarily anti-inflammatory. The researchers are attempting to 
duplicate this effect in nonpregnant patients with rheumatoid arthritis 
by vaccination with white blood cells from other individuals, preferably 
the patient's spouse. The investigators postulate that the clinical 
response may be better when the vaccine contains cells from a spouse 
because of repeated exposure to spouse human-leucocyte antigen or 
other antigens through sexual intercourse. 
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In early clinical tests, significant improvement in symptoms and 
clinical course of the disease was noted in 73 percent of patients treated 
with the vaccine. The results of placebo-controlled trials in the near 
future will determine whether this technique can be applied safely in 
all rheumatoid arthritis patients, both male and female. 
Lance Simpson, Ph.D., Director of the Clinical Center for Occupational 
and Environmental Medicine, and molecular biologist colleagues have 
formulated an oral vaccine against botulism which may be used as a 
prototype for vaccines against other diseases such as diphtheria, 
whooping cough, and tetanus. The team created a modified version of 
the botulism toxin that can enter the bloodstream but causes no toxic 
effect on the patient's nervous system. This oral vaccine against 
botulism could have application in both human and veterinary 
medicine. 
Hilary Koprowski, M.D., Professor of Microbiology and Immunology, 
has led several thought-provoking studies at Jefferson. He and 
D. Craig Hooper, Ph.D., 
Assistant Professor, have shown 
that uric acid, a common 
metabolic product, may lessen 
symptoms of a mouse disease 
considered a model for human 
multiple sclerosis. Uric acid 
lessened weakness and paralysis 
and prolonged survival in mice 
with experimental allergic 
encephalitis. Interestingly, uric 
acid inactivates a toxic 
compound, peroxynitrite, which 
has been implicated in the progressive central nervous system damage 
that characterizes multiple sclerosis. 
Several other findings suggest that uric acid may play a role in multiple 
sclerosis. Investigators found significantly lower levels of uric acid in 
the blood of MS patients than in age-matched controls with other 
neurological diseases. A review of extensive patient medical records 
also shows that gout—which is marked by excessive levels of uric 
acid— and multiple sclerosis are almost mutually exclusive. Dr. 
Koprowski and his colleagues are planning a clinical trial to measure 
how well uric acid may halt MS symptoms in humans with progressive 
disease. 
Early in 1998, the Jefferson Center for Biomedical Research was created 
on the campus of the Delaware Valley College of Science and 
Agriculture in Doylestown, Pennsylvania. The college built and leased 
to Jefferson a new wing containing molecular biology laboratories and 
animal quarters. The center is designed to apply scientific and agricul-
tural resources to biomedical problems and to foster partnerships with 
commercial scientists. 
Timothy M. Bloch, Ph.D., Associate Professor of Microbiology and 
Immunology at Jefferson, directs the center's 22 full time scientists and 
staff. Professor Koprowski is conducting basic research there on 
manipulation of vegetable DNA for ultimate use in humans. Initiatives 
include the study of viral hepatitis and emerging human diseases, the 
development of viral therapeutics and new strategies for gene therapy, 
and the use of plants as "functional foods" for vaccine delivery. The 
center is the home of the Hepatitis B Foundation, a national nonprofit 
organization dedicated to the elimination of hepatitis B. 
CONNECTIVE TISSUE 
An interdisciplinary team at the Center City campus led by Sergio A. 
Jimenez, M.D., the Dorrance Hamilton Professor of Medicine, is 
supported by a four-year, $3.7 million grant from NIH to investigate 
possible genetic causes of osteoarthritis, or degenerative joint disease. 
Individual projects span several departments. Osteoarthritis affects an 
estimated 16 million Americans, and is sometimes present in several 
generations of the same family. By age 65, three-quarters of the 
American population show x-ray evidence of osteoarthritis in at least 
one joint. It is a major cause of disability and job absenteeism, costing 
the national economy tens of billions of dollars in workers' disability 
and lost productivity. 
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The principal emphasis of the Department of Dermatology and 
Cutaneous Biology is the extracellular matrix of connective tissue. 
Eleven research laboratories are run by independent investigators. 
• Department chair Jouni Uitto, M.D., Ph.D. is concentrating on 
epidermolysis bullosa (EB), a group of heritable blistering skin diseases 
affecting the cutaneous basement membrane zone. Department investi-
gators were the first to clone several genes that affect this zone, and to 
identify mutations in eight of the 10 genes now known to underlie 
different variations of EB. The department also provides DNA-based 
prenatal testing for families worldwide affected by EB. 
• In collaboration with researchers from the United Kingdom, investi-
gators have cloned and sequenced a gene which underlies a subtype of 
EB associated with late onset muscular dystrophy. The findings suggest 
that a defect or deficiency of plectin, a protein involved in anchoring 
skin layers, underlies this condition. This study demonstrates that EB 
affects muscle as well as skin layers—information that will allow earlier 
diagnosis of muscular dystrophy in infants born with skin blistering, as 
well as DNA-based prenatal testing for the disease. 
• The department's transgenic animal facility has developed a 
"knockout" mouse which mimics recessive dystrophic EB and serves as 
a model system to test therapeutic approaches. Associate Professor 
Kyonggeun Yoon, Ph.D. is devising more efficient gene therapy for EB 
and other heritable skin diseases through the use of short strands of 
genetic material known as chimeric oligonucleotide hybrid molecules, 
employing a genetic cut-and-paste technique that she developed with 
Associate Professor Eric Kmiec, Ph.D. These small snippets include 
both RNA and DNA; the host DNA's repair mechanism automatically 
incorporates these oligonucleotide patches. 
Research in Dermatology and Cutaneous Biology covers other bases as 
well: 
• Associate Professor Alain Mauviel, Ph.D. is working on the character-
ization of cytokine response elements within the promoter region of 
extracellular matrix genes. 
• Professor Frances Gasparro, Ph.D. directs the Photobiology 
Laboratory, which examines cellular events that lead to the 
development of skin cancers as a result of psoralen and ultraviolet light. 
• Professor Mon-Li Chu, Ph.D. is uncovering the functions of novel 
extracellular matrix proteins in the skin. She recently found two such 
proteins through DNA cloning. 
• Irwin McLean, Ph.D. and Frances Smith, Ph.D. and their Epithelial 
Genetics Group study disorders in the structural integrity and differen-
tiation of epithelial tissues, with an emphasis on cytoskeletal and 
associated connector molecules. 
THE FUTURE IS Now 
Far-reaching achievements in education, basic, translational, and 
clinical research, and patient care position Jefferson today as one of the 
best-balanced medical schools in the country. 
The sun is shining brightly as we enter the next millennium. To keep 
the clouds away we need continued prudent leadership from the 
administration and the board of trustees; unabated recruitment of 
clinicians and scientists who demonstrate productivity and teaching 
skill; a stable environment of health care delivery; enthusiastic support 
from Jefferson's alumni and friends—and the participation of all who 
are energized by the excellence of Jefferson today and the promise of 
Jefferson in the years to come.4 
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